Have a language expert improve your writing
Run a free plagiarism check in 10 minutes, generate accurate citations for free.
- Knowledge Base
- Methodology
- What Is an Observational Study? | Guide & Examples

What Is an Observational Study? | Guide & Examples
Published on March 31, 2022 by Tegan George . Revised on December 2, 2022.
An observational study is used to answer a research question based purely on what the researcher observes. There is no interference or manipulation of the research subjects, and no control and treatment groups .
These studies are often qualitative in nature and can be used for both exploratory and explanatory research purposes. While quantitative observational studies exist, they are less common.
Observational studies are generally used in hard science, medical, and social science fields. This is often due to ethical or practical concerns that prevent the researcher from conducting a traditional experiment . However, the lack of control and treatment groups means that forming inferences is difficult, and there is a risk of confounding variables and observer bias impacting your analysis.
Table of contents
Types of observation, types of observational studies, observational study example, advantages and disadvantages of observational studies, observational study vs. experiment, frequently asked questions.
There are many types of observation, and it can be challenging to tell the difference between them. Here are some of the most common types to help you choose the best one for your observational study.
There are three main types of observational studies: cohort studies, case–control studies, and cross-sectional studies .
Cohort studies
Cohort studies are more longitudinal in nature, as they follow a group of participants over a period of time. Members of the cohort are selected because of a shared characteristic, such as smoking, and they are often observed over a period of years.
Case–control studies
Case–control studies bring together two groups, a case study group and a control group . The case study group has a particular attribute while the control group does not. The two groups are then compared, to see if the case group exhibits a particular characteristic more than the control group.
For example, if you compared smokers (the case study group) with non-smokers (the control group), you could observe whether the smokers had more instances of lung disease than the non-smokers.
Cross-sectional studies
Cross-sectional studies analyze a population of study at a specific point in time.
This often involves narrowing previously collected data to one point in time to test the prevalence of a theory—for example, analyzing how many people were diagnosed with lung disease in March of a given year. It can also be a one-time observation, such as spending one day in the lung disease wing of a hospital.
Receive feedback on language, structure, and formatting
Professional editors proofread and edit your paper by focusing on:
- Academic style
- Vague sentences
- Style consistency
See an example

Observational studies are usually quite straightforward to design and conduct. Sometimes all you need is a notebook and pen! As you design your study, you can follow these steps.
Step 1: Identify your research topic and objectives
The first step is to determine what you’re interested in observing and why. Observational studies are a great fit if you are unable to do an experiment for practical or ethical reasons , or if your research topic hinges on natural behaviors.
Step 2: Choose your observation type and technique
In terms of technique, there are a few things to consider:
- Are you determining what you want to observe beforehand, or going in open-minded?
- Is there another research method that would make sense in tandem with an observational study?
- If yes, make sure you conduct a covert observation.
- If not, think about whether observing from afar or actively participating in your observation is a better fit.
- How can you preempt confounding variables that could impact your analysis?
- You could observe the children playing at the playground in a naturalistic observation.
- You could spend a month at a day care in your town conducting participant observation, immersing yourself in the day-to-day life of the children.
- You could conduct covert observation behind a wall or glass, where the children can’t see you.
Overall, it is crucial to stay organized. Devise a shorthand for your notes, or perhaps design templates that you can fill in. Since these observations occur in real time, you won’t get a second chance with the same data.
Step 3: Set up your observational study
Before conducting your observations, there are a few things to attend to:
- Plan ahead: If you’re interested in day cares, you’ll need to call a few in your area to plan a visit. They may not all allow observation, or consent from parents may be needed, so give yourself enough time to set everything up.
- Determine your note-taking method: Observational studies often rely on note-taking because other methods, like video or audio recording, run the risk of changing participant behavior.
- Get informed consent from your participants (or their parents) if you want to record: Ultimately, even though it may make your analysis easier, the challenges posed by recording participants often make pen-and-paper a better choice.
Step 4: Conduct your observation
After you’ve chosen a type of observation, decided on your technique, and chosen a time and place, it’s time to conduct your observation.
Here, you can split them into case and control groups. The children with siblings have a characteristic you are interested in (siblings), while the children in the control group do not.
When conducting observational studies, be very careful of confounding or “lurking” variables. In the example above, you observed children as they were dropped off, gauging whether or not they were upset. However, there are a variety of other factors that could be at play here (e.g., illness).
Step 5: Analyze your data
After you finish your observation, immediately record your initial thoughts and impressions, as well as follow-up questions or any issues you perceived during the observation. If you audio- or video-recorded your observations, you can transcribe them.
Your analysis can take an inductive or deductive approach :
- If you conducted your observations in a more open-ended way, an inductive approach allows your data to determine your themes.
- If you had specific hypotheses prior to conducting your observations, a deductive approach analyzes whether your data confirm those themes or ideas you had previously.
Next, you can conduct your thematic or content analysis . Due to the open-ended nature of observational studies, the best fit is likely thematic analysis .
Step 6: Discuss avenues for future research
Observational studies are generally exploratory in nature, and they often aren’t strong enough to yield standalone conclusions due to their very high susceptibility to observer bias and confounding variables. For this reason, observational studies can only show association, not causation .
If you are excited about the preliminary conclusions you’ve drawn and wish to proceed with your topic, you may need to change to a different research method , such as an experiment.
- Observational studies can provide information about difficult-to-analyze topics in a low-cost, efficient manner.
- They allow you to study subjects that cannot be randomized safely, efficiently, or ethically .
- They are often quite straightforward to conduct, since you just observe participant behavior as it happens or utilize preexisting data.
- They’re often invaluable in informing later, larger-scale clinical trials or experimental designs.
Disadvantages
- Observational studies struggle to stand on their own as a reliable research method. There is a high risk of observer bias and undetected confounding variables or omitted variables .
- They lack conclusive results, typically are not externally valid or generalizable, and can usually only form a basis for further research.
- They cannot make statements about the safety or efficacy of the intervention or treatment they study, only observe reactions to it. Therefore, they offer less satisfying results than other methods.
The key difference between observational studies and experiments is that a properly conducted observational study will never attempt to influence responses, while experimental designs by definition have some sort of treatment condition applied to a portion of participants.
However, there may be times when it’s impossible, dangerous, or impractical to influence the behavior of your participants. This can be the case in medical studies, where it is unethical or cruel to withhold potentially life-saving intervention, or in longitudinal analyses where you don’t have the ability to follow your group over the course of their lifetime.
An observational study may be the right fit for your research if random assignment of participants to control and treatment groups is impossible or highly difficult. However, the issues observational studies raise in terms of validity , confounding variables, and conclusiveness can mean that an experiment is more reliable.
If you’re able to randomize your participants safely and your research question is definitely causal in nature, consider using an experiment.
An observational study is a great choice for you if your research question is based purely on observations. If there are ethical, logistical, or practical concerns that prevent you from conducting a traditional experiment , an observational study may be a good choice. In an observational study, there is no interference or manipulation of the research subjects, as well as no control or treatment groups .
The key difference between observational studies and experimental designs is that a well-done observational study does not influence the responses of participants, while experiments do have some sort of treatment condition applied to at least some participants by random assignment .
A quasi-experiment is a type of research design that attempts to establish a cause-and-effect relationship. The main difference with a true experiment is that the groups are not randomly assigned.
Exploratory research aims to explore the main aspects of an under-researched problem, while explanatory research aims to explain the causes and consequences of a well-defined problem.
Experimental design means planning a set of procedures to investigate a relationship between variables . To design a controlled experiment, you need:
- A testable hypothesis
- At least one independent variable that can be precisely manipulated
- At least one dependent variable that can be precisely measured
When designing the experiment, you decide:
- How you will manipulate the variable(s)
- How you will control for any potential confounding variables
- How many subjects or samples will be included in the study
- How subjects will be assigned to treatment levels
Experimental design is essential to the internal and external validity of your experiment.
Cite this Scribbr article
If you want to cite this source, you can copy and paste the citation or click the “Cite this Scribbr article” button to automatically add the citation to our free Citation Generator.
George, T. (2022, December 02). What Is an Observational Study? | Guide & Examples. Scribbr. Retrieved February 27, 2023, from https://www.scribbr.com/methodology/observational-study/
Is this article helpful?
Tegan George
Other students also liked, what is a research design | types, guide & examples, guide to experimental design | overview, steps, & examples, naturalistic observation | definition, guide & examples, what is your plagiarism score.
Lesson 1: Introduction to Epidemiology
Section 7: analytic epidemiology.
As noted earlier, descriptive epidemiology can identify patterns among cases and in populations by time, place and person. From these observations, epidemiologists develop hypotheses about the causes of these patterns and about the factors that increase risk of disease. In other words, epidemiologists can use descriptive epidemiology to generate hypotheses, but only rarely to test those hypotheses. For that, epidemiologists must turn to analytic epidemiology.
Key feature of analytic epidemiology = Comparison group
The key feature of analytic epidemiology is a comparison group. Consider a large outbreak of hepatitis A that occurred in Pennsylvania in 2003.( 38 ) Investigators found almost all of the case-patients had eaten at a particular restaurant during the 2–6 weeks (i.e., the typical incubation period for hepatitis A) before onset of illness. While the investigators were able to narrow down their hypotheses to the restaurant and were able to exclude the food preparers and servers as the source, they did not know which particular food may have been contaminated. The investigators asked the case-patients which restaurant foods they had eaten, but that only indicated which foods were popular. The investigators, therefore, also enrolled and interviewed a comparison or control group — a group of persons who had eaten at the restaurant during the same period but who did not get sick. Of 133 items on the restaurant’s menu, the most striking difference between the case and control groups was in the proportion that ate salsa (94% of case-patients ate, compared with 39% of controls). Further investigation of the ingredients in the salsa implicated green onions as the source of infection. Shortly thereafter, the Food and Drug Administration issued an advisory to the public about green onions and risk of hepatitis A. This action was in direct response to the convincing results of the analytic epidemiology, which compared the exposure history of case-patients with that of an appropriate comparison group.
When investigators find that persons with a particular characteristic are more likely than those without the characteristic to contract a disease, the characteristic is said to be associated with the disease. The characteristic may be a:
- Demographic factor such as age, race, or sex;
- Constitutional factor such as blood group or immune status;
- Behavior or act such as smoking or having eaten salsa; or
- Circumstance such as living near a toxic waste site.
Identifying factors associated with disease help health officials appropriately target public health prevention and control activities. It also guides additional research into the causes of disease.
Thus, analytic epidemiology is concerned with the search for causes and effects, or the why and the how. Epidemiologists use analytic epidemiology to quantify the association between exposures and outcomes and to test hypotheses about causal relationships. It has been said that epidemiology by itself can never prove that a particular exposure caused a particular outcome. Often, however, epidemiology provides sufficient evidence to take appropriate control and prevention measures.
Epidemiologic studies fall into two categories: experimental and observational .
Experimental studies
In an experimental study, the investigator determines through a controlled process the exposure for each individual (clinical trial) or community (community trial), and then tracks the individuals or communities over time to detect the effects of the exposure. For example, in a clinical trial of a new vaccine, the investigator may randomly assign some of the participants to receive the new vaccine, while others receive a placebo shot. The investigator then tracks all participants, observes who gets the disease that the new vaccine is intended to prevent, and compares the two groups (new vaccine vs. placebo) to see whether the vaccine group has a lower rate of disease. Similarly, in a trial to prevent onset of diabetes among high-risk individuals, investigators randomly assigned enrollees to one of three groups — placebo, an anti-diabetes drug, or lifestyle intervention. At the end of the follow-up period, investigators found the lowest incidence of diabetes in the lifestyle intervention group, the next lowest in the anti-diabetic drug group, and the highest in the placebo group.( 39 )
Observational studies
In an observational study, the epidemiologist simply observes the exposure and disease status of each study participant. John Snow’s studies of cholera in London were observational studies. The two most common types of observational studies are cohort studies and case-control studies; a third type is cross-sectional studies.
Cohort study. A cohort study is similar in concept to the experimental study. In a cohort study the epidemiologist records whether each study participant is exposed or not, and then tracks the participants to see if they develop the disease of interest. Note that this differs from an experimental study because, in a cohort study, the investigator observes rather than determines the participants’ exposure status. After a period of time, the investigator compares the disease rate in the exposed group with the disease rate in the unexposed group. The unexposed group serves as the comparison group, providing an estimate of the baseline or expected amount of disease occurrence in the community. If the disease rate is substantively different in the exposed group compared to the unexposed group, the exposure is said to be associated with illness.
The length of follow-up varies considerably. In an attempt to respond quickly to a public health concern such as an outbreak, public health departments tend to conduct relatively brief studies. On the other hand, research and academic organizations are more likely to conduct studies of cancer, cardiovascular disease, and other chronic diseases which may last for years and even decades. The Framingham study is a well-known cohort study that has followed over 5,000 residents of Framingham, Massachusetts, since the early 1950s to establish the rates and risk factors for heart disease.( 7 ) The Nurses Health Study and the Nurses Health Study II are cohort studies established in 1976 and 1989, respectively, that have followed over 100,000 nurses each and have provided useful information on oral contraceptives, diet, and lifestyle risk factors.( 40 ) These studies are sometimes called follow-up or prospective cohort studies, because participants are enrolled as the study begins and are then followed prospectively over time to identify occurrence of the outcomes of interest.
An alternative type of cohort study is a retrospective cohort study. In this type of study both the exposure and the outcomes have already occurred. Just as in a prospective cohort study, the investigator calculates and compares rates of disease in the exposed and unexposed groups. Retrospective cohort studies are commonly used in investigations of disease in groups of easily identified people such as workers at a particular factory or attendees at a wedding. For example, a retrospective cohort study was used to determine the source of infection of cyclosporiasis, a parasitic disease that caused an outbreak among members of a residential facility in Pennsylvania in 2004.( 41 ) The investigation indicated that consumption of snow peas was implicated as the vehicle of the cyclosporiasis outbreak.
Case-control study. In a case-control study, investigators start by enrolling a group of people with disease (at CDC such persons are called case-patients rather than cases, because case refers to occurrence of disease, not a person). As a comparison group, the investigator then enrolls a group of people without disease (controls). Investigators then compare previous exposures between the two groups. The control group provides an estimate of the baseline or expected amount of exposure in that population. If the amount of exposure among the case group is substantially higher than the amount you would expect based on the control group, then illness is said to be associated with that exposure. The study of hepatitis A traced to green onions, described above, is an example of a case-control study. The key in a case-control study is to identify an appropriate control group, comparable to the case group in most respects, in order to provide a reasonable estimate of the baseline or expected exposure.
Cross-sectional study. In this third type of observational study, a sample of persons from a population is enrolled and their exposures and health outcomes are measured simultaneously. The cross-sectional study tends to assess the presence (prevalence) of the health outcome at that point of time without regard to duration. For example, in a cross-sectional study of diabetes, some of the enrollees with diabetes may have lived with their diabetes for many years, while others may have been recently diagnosed.
From an analytic viewpoint the cross-sectional study is weaker than either a cohort or a case-control study because a cross-sectional study usually cannot disentangle risk factors for occurrence of disease (incidence) from risk factors for survival with the disease. (Incidence and prevalence are discussed in more detail in Lesson 3.) On the other hand, a cross-sectional study is a perfectly fine tool for descriptive epidemiology purposes. Cross-sectional studies are used routinely to document the prevalence in a community of health behaviors (prevalence of smoking), health states (prevalence of vaccination against measles), and health outcomes, particularly chronic conditions (hypertension, diabetes).
In summary, the purpose of an analytic study in epidemiology is to identify and quantify the relationship between an exposure and a health outcome. The hallmark of such a study is the presence of at least two groups, one of which serves as a comparison group. In an experimental study, the investigator determines the exposure for the study subjects; in an observational study, the subjects are exposed under more natural conditions. In an observational cohort study, subjects are enrolled or grouped on the basis of their exposure, then are followed to document occurrence of disease. Differences in disease rates between the exposed and unexposed groups lead investigators to conclude that exposure is associated with disease. In an observational case-control study, subjects are enrolled according to whether they have the disease or not, then are questioned or tested to determine their prior exposure. Differences in exposure prevalence between the case and control groups allow investigators to conclude that the exposure is associated with the disease. Cross-sectional studies measure exposure and disease status at the same time, and are better suited to descriptive epidemiology than causation.
Exercise 1.7
Classify each of the following studies as:
- Experimental
- Observational cohort
- Observational case-control
- Observational cross-sectional
- Not an analytical or epidemiologic study
- ____ 1. Representative sample of residents were telephoned and asked how much they exercise each week and whether they currently have (have ever been diagnosed with) heart disease.
- ____ 2. Occurrence of cancer was identified between April 1991 and July 2002 for 50,000 troops who served in the first Gulf War (ended April 1991) and 50,000 troops who served elsewhere during the same period.
- ____ 3. Persons diagnosed with new-onset Lyme disease were asked how often they walk through woods, use insect repellant, wear short sleeves and pants, etc. Twice as many patients without Lyme disease from the same physician’s practice were asked the same questions, and the responses in the two groups were compared.
- ____ 4. Subjects were children enrolled in a health maintenance organization. At 2 months, each child was randomly given one of two types of a new vaccine against rotavirus infection. Parents were called by a nurse two weeks later and asked whether the children had experienced any of a list of side-effects.
Check your answer.
References (This Section)
- Kannel WB. The Framingham Study: its 50-year legacy and future promise. J Atheroscler Thromb 2000;6:60-6.
Exit Notification / Disclaimer Policy
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.
Study Design 101
- Helpful formulas
- Finding specific study types
Case Report
- Meta- Analysis
- Systematic Review
- Practice Guideline
- Randomized Controlled Trial
- Cohort Study
- Case Control Study
- Case Reports
An article that describes and interprets an individual case, often written in the form of a detailed story. Case reports often describe:
- Unique cases that cannot be explained by known diseases or syndromes
- Cases that show an important variation of a disease or condition
- Cases that show unexpected events that may yield new or useful information
- Cases in which one patient has two or more unexpected diseases or disorders
Case reports are considered the lowest level of evidence, but they are also the first line of evidence, because they are where new issues and ideas emerge. This is why they form the base of our pyramid. A good case report will be clear about the importance of the observation being reported.
If multiple case reports show something similar, the next step might be a case-control study to determine if there is a relationship between the relevant variables.
- Can help in the identification of new trends or diseases
- Can help detect new drug side effects and potential uses (adverse or beneficial)
- Educational – a way of sharing lessons learned
- Identifies rare manifestations of a disease
Disadvantages
- Cases may not be generalizable
- Not based on systematic studies
- Causes or associations may have other explanations
- Can be seen as emphasizing the bizarre or focusing on misleading elements
Design pitfalls to look out for
The patient should be described in detail, allowing others to identify patients with similar characteristics.
Does the case report provide information about the patient's age, sex, ethnicity, race, employment status, social situation, medical history, diagnosis, prognosis, previous treatments, past and current diagnostic test results, medications, psychological tests, clinical and functional assessments, and current intervention?
Case reports should include carefully recorded, unbiased observations.
Does the case report include measurements and/or recorded observations of the case? Does it show a bias?
Case reports should explore and infer, not confirm, deduce, or prove. They cannot demonstrate causality or argue for the adoption of a new treatment approach.
Does the case report present a hypothesis that can be confirmed by another type of study?
Fictitious Example
A physician treated a young and otherwise healthy patient who came to her office reporting numbness all over her body. The physician could not determine any reason for this numbness and had never seen anything like it. After taking an extensive history the physician discovered that the patient had recently been to the beach for a vacation and had used a very new type of spray sunscreen. The patient had stored the sunscreen in her cooler at the beach because she liked the feel of the cool spray in the hot sun. The physician suspected that the spray sunscreen had undergone a chemical reaction from the coldness which caused the numbness. She also suspected that because this is a new type of sunscreen other physicians may soon be seeing patients with this numbness.
The physician wrote up a case report describing how the numbness presented, how and why she concluded it was the spray sunscreen, and how she treated the patient. Later, when other doctors began seeing patients with this numbness, they found this case report helpful as a starting point in treating their patients.
Real-life Examples
Hymes KB. Cheung T. Greene JB. Prose NS. Marcus A. Ballard H. William DC. Laubenstein LJ. (1981). Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet. 2(8247), 598-600.
This case report was published by eight physicians in New York city who had unexpectedly seen eight male patients with Kaposi’s sarcoma (KS). Prior to this, KS was very rare in the U.S. and occurred primarily in the lower extremities of older patients. These cases were decades younger, had generalized KS, and a much lower rate of survival. This was before the discovery of HIV or the use of the term AIDS and this case report was one of the first published items about AIDS patients.
Wu, E. B., & Sung, J. J. Y. (2003). Haemorrhagic-fever-like changes and normal chest radiograph in a doctor with SARS. Lancet, 361(9368), 1520-1521.
This case report is written by the patient, a physician who contracted SARS, and his colleague who treated him, during the 2003 outbreak of SARS in Hong Kong. They describe how the disease progressed in Dr. Wu and based on Dr. Wu’s case, advised that a chest CT showed hidden pneumonic changes and facilitate a rapid diagnosis.
Related Terms
Case Series
A report about a small group of similar cases.
Preplanned Case-Observation
A case in which symptoms are elicited to study disease mechanisms. (Ex. Having a patient sleep in a lab to do brain imaging for a sleep disorder).
Now test yourself!
1. Case studies are not considered evidence-based even though the authors have studied the case in great depth.
a) True b) False
2. When are Case reports most useful?
a) When you encounter common cases and need more information b) When new symptoms or outcomes are unidentified c) When developing practice guidelines d) When the population being studied is very large
← Previous Next →
© 2011-2019, The Himmelfarb Health Sciences Library Questions? Ask us .

- Himmelfarb Intranet
- Privacy Notice
- Terms of Use
- GW is committed to digital accessibility. If you experience a barrier that affects your ability to access content on this page, let us know via the Accessibility Feedback Form .

PH717 Module 1B - Descriptive Tools
Descriptive epidemiology & descriptive statistics.
- Page:
- 1
- | 2
- | 3
- | 4
- | 5
- | 6
- | 7
- | 8
- | 9

Case Reports and Case Series
Case reports, case series, test yourself.

Categories of Descriptive Epidemiology
A case report is a detailed description of disease occurrence in a single person. Unusual features of the case may suggest a new hypothesis about the causes or mechanisms of disease.
Example: Acquired Immunodeficiency in an Infant; Possible Transmission by Means of Blood Products
In April 1983 it had not yet been shown that AIDS could be transmitted by blood or blood products. An infant born with Rh incompatibility; required blood products from 18 donors over 8 weeks and subsequently developed unusual recurrent infections with opportunistic agents such as Candida. The infant's T cell count was low, suggesting AIDS. There was no family history of immunodeficiency, but one of the blood donors was found to have died of AIDS. This led the investigators to hypothesize that AIDS could be transmitted by blood transfusion.
Link to article by Ammann AJ et al: Acquired immunodeficiency in an infant: possible transmission by means of blood products. The Lancet 1:956-958, 1983.
A case series is a report on the characteristics of a group of subjects who all have a particular disease or condition. Common features among the group may suggest hypotheses about disease causation. Note that the "series" may be small (as in the example below) or it may be large (hundreds or thousands of "cases"). However, the chief limitation is that there is no comparison group. Consequently, common features may suggest hypotheses, but these need to be tested with some sort of analytical study before an association can be accepted as valid.
Example: Discovery of HIV in the United States

This was an extraordinarily important case series (a detailed description of characteristics of a series of people who all have the same disease) that suggested that this new syndrome was associated with sexual activity in male homosexuals. Alerting the medical establishment and proposing a hypothesis was an important milestone in the AIDS epidemic.
Link to article by Gottlieb MS, et al: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425-1431.
There had been a number of case reports of liver cancers in young women taking oral contraceptives. A study was undertaken by contacting all of the cancer registries collaborating with the American College of Surgeons. The investigators wanted to collect information on as many of these rare liver tumors as possible across the US.
Table - Oral Contraceptive Use Among Women Who Developed Liver Cancer
What conclusions can you draw from these data regarding a possible increased risk of liver cancer in woman taking oral contraceptives? Think about it before you look at the answer.
return to top | previous page | next page
Content ©2020. All Rights Reserved. Date last modified: September 10, 2020. Wayne W. LaMorte, MD, PhD, MPH

Strengthening the reporting of observational studies in epidemiology
What is STROBE?
STROBE stands for an international, collaborative initiative of epidemiologists, methodologists, statisticians, researchers and journal editors involved in the conduct and dissemination of observational studies, with the common aim of STrengthening the Reporting of OBservational studies in Epidemiology .
For STROBE-related entries in PubMed click here .
Aims and use of STROBE
Incomplete and inadequate reporting of research hampers the assessment of the strengths and weaknesses of the studies reported in the medical literature. Readers need to know what was planned (and what was not), what was done, what was found, and what the results mean. Recommendations on the reporting of studies that are endorsed by leading medical journals can improve the quality of reporting.
Observational research comprises several study designs and many topic areas. We aimed to establish a checklist of items that should be included in articles reporting such research – the STROBE Statement. We considered it reasonable to initially restrict the recommendations to the three main analytical designs that are used in observational research: cohort, case-control, and cross-sectional studies. We want to provide guidance on how to report observational research well. Our recommendations are not prescriptions for designing or conducting studies. Also, the checklist is not an instrument to evaluate the quality of observational research.
Further use
The STROBE initiative should be seen as an ongoing process, with future revisions of the recommendations based on comments, critique and new evidence. We welcome translations into other languages and extensions to other observational study designs, for example nested case-control studies, and specific topic areas, for example, genetic and molecular epidemiology.
Note : We ask anyone intending to use the STROBE Statement for further extensions, translations or other STROBE-related work to contact the coordinating group through this website first. This will allow to coordinate efforts and to avoid duplication. The authors of the original STROBE articles hold the copyright. Please, contact us if you wish to re-publish STROBE material in additional journals, books or other media.
All documents and publications produced by the STROBE Initiative are open-access and available for download on this website.
Observational Studies I Case Report, Case Series, Case-Control Study
Terms in this set (24)

Other sets by this creator
Extreme weather events, ecotoxicity and oceans, resource depletion and extraction, public health ethics, verified questions.
An NMOS differential pair is to be used in an amplifier whose drain resistors are 10 k Ω ± 1 % . 10 \mathrm{k} \Omega \pm 1 \% . 10 k Ω ± 1%. For the pair, k n ′ W / L = 4 m A / V 2 . k_{n}^{\prime} W / L=4 \mathrm{m} \mathrm{A} / \mathrm{V}^{2}. k n ′ W / L = 4 mA / V 2 . A decision is to be made concerning the bias current I to be used, whether 160 μ A 160 \mu \mathrm{A} 160 μ A or 360 μ A . 360 \mu \mathrm{A}. 360 μ A . Contrast the differential gain and input offset voltage for the two possibilities.
What is the lewis structure of A s H X 3 \ce{AsH3} AsH X 3 ?
A two-fluid heat exchanger has inlet and outlet temperatures of 65 and 4 0 ∘ C 40^{\circ} \mathrm{C} 4 0 ∘ C for the hot fluid and 15 and 3 0 ∘ C 30^{\circ} \mathrm{C} 3 0 ∘ C for the cold fluid. Can you tell whether this exchanger is operating under counterflow or parallelflow conditions? Determine the effectiveness of the heat exchanger.
Air of capacity 2.3 l b m o l 2.3 \mathrm{~lbmol} 2.3 lbmol at 6 5 ∘ F 65^{\circ} \mathrm{F} 6 5 ∘ F and 32 p s i a 32 \mathrm{~psia} 32 psia is contained in an elastic tank. What is the volume of the tank? If the volume is doubled at the same pressure, Find the final temperature.
Recommended textbook solutions

Pharmacology and the Nursing Process

The Human Body in Health and Disease

Integrated Electronic Health Records

Health: The Basics
Other quizlet sets, exam 2 ch 7-14.

EPID 4070 Study Guide
Epidemiology Chapter 4

The Science of Evidence Based Medicine
User Preferences
Content preview.
Arcu felis bibendum ut tristique et egestas quis:
- Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
- Duis aute irure dolor in reprehenderit in voluptate
- Excepteur sint occaecat cupidatat non proident
Keyboard Shortcuts
3.2 - controlled clinical trials compared to observational studies.
Medical research, as a scientific investigation, is based on careful observation and theory. Theory directs the observation and provides a basis for interpreting the results. The strength of the evidence from a clinical study is proportional to amount of the control of bias and variability when the study was conducted as well as the magnitude of the observed effect. Clinical studies can be characterized as uncontrolled observations, observational comparative and controlled clinical trials.
Case reports and case-series are uncontrolled observational studies.
Case Report
A case report only demonstrates that a clinical event of interest is possible. In a case report, there is no control of treatment assignment, endpoint ascertainment, or confounders. There is no control group for the sake of comparison. The report is descriptive in nature, not a formal statistical analysis.
Case reports are useful in generating hypotheses for future testing. For example, a physician may report that a patient in his practice, who was taking a specific anorexic drug, developed primary pulmonary hypertension (PPH), a rare condition that occurs in 1-2 out of every million Americans. Is this convincing evidence that the anorexic drug causes PPH?
Case Series
A case series carries more weight than a single case report, but cannot prove the efficacy of a treatment. Case series and case reports are susceptible to large selection biases. Consider the example of laetrile, an apricot pit extract that was reputed to cure cancer. Seven case series were reported; the strength of evidence from these studies has been summarized by the US National Cancer Institute ( NCI ). While a proportion of patients may have experienced spontaneous remission of cancer, rigorous testing in controlled environments was never performed. After an estimated 70,000 patients had been treated, the NCI undertook a retrospective analysis of laetrile only to decide no definite conclusions supporting anti-cancer activity could be made ( Special Report on Laetrile: The NCI Laetrile Review ). The Cochrane review on laetrile (2015), states, “ there is no reliable evidence for the alleged effects of laetrile or amygdalin for curative effects in cancer patients. ” Based on a series of reported cases, many believed laetrile would cure their cancer, perhaps refusing other effective treatments, and subjecting themselves to adverse effects of cyanide, for many years, this continued for many years with anti-tumor efficacy of laetrile unsupported while associated adverse effects were coming to light.
Database Analysis
A database analysis is similar to a case series but may have a control group, depending on the data source. The source and quality of the data used for this secondary analysis are key. If the analysis attempts to evaluate treatment differences from data in which treatment assignment was based on physician and patient discretion, nonrandomized and open-label, bias is likely.
Databases are best used to study patterns with exploratory statistical analyses. For example, the NIH sponsored a database analysis of interstitial cystitis (IC) during the 1990s. This consisted of data from over 400 individuals with IC who underwent various and numerous therapies for their condition. The objective of the database analysis was to determine if there were patterns of treatments that may be effective in treating the disease. (Rovner et al. 2000).
As another example, in the case of genomic research, specific data mining tools have been developed to search for patterns in large databases of genetic data, leading to the discovery of particular candidate genes.
Epidemiologic Study
An epidemiologic study is often a case-control or a cohort design, both comparative observational studies. An observational study lacks the key component of an experiment, namely, control over treatment assignment. Commonly these designs are used in assessing the influence of risk factors for a disease. Subjects meeting entrance criteria may have been identified through a database search. The choice of the control group is a crucial design component in observational studies.
Case-Control Study
In a case-control study , the investigator identifies cases (subjects with the disease) and controls (subjects without the disease) and retrospectively assesses some type of treatment or exposure. Because the investigator has selected the cases and controls, relative risk cannot be calculated directly from a case-control study.
In addition, levels of treatment or exposure may be recorded based on a subject’s recall of events that occurred many years previously, thus recall bias,(systematic differences in accuracy or completeness of recall) can affect the study results.
Prospective Cohort Study
In a prospective cohort study , individuals are followed forward in time with subsequent evaluations to determine which individuals develop into cases. The relationship of specific risk factors that were measured at baseline with the subsequent outcome is assessed. The cohort study may consist of one or more samples with particular risk factors, called cohorts . It is possible to control some sources of bias in a prospective cohort study by following standard procedures in collecting data and ascertaining endpoints. Since the subjects are not assigned risk factors in a randomized manner, however, there may remain covariates that are confounded with a risk factor. Sometimes, a particular treatment group (or groups) from a randomized trial is followed as a cohort, providing a cohort in which the treatment was assigned at random.
Prospective studies tend to have fewer design problems and less bias than retrospective studies, but they are more expensive with respect to time and cost.
An example of a case-control study: A cardiologist identifies 36 patients currently in his practice with a specific form of cardiac valve disease. He identifies another group of relatively healthy patients and matches two of them to each of the patients with cardiac valve disease according to age (± 5years) and BMI (± 2.5). He plans to interview all 36 + 72 = 108 patients to assess their use of diet drugs during the past ten years.
A classic example of a cohort study: U.S. National Heart Lung and Blood Institute Framingham Heart Study
Piantodosi (2005) lists the following conditions for convincing non-experimental comparative studies:
- The treatment of interest occurs naturally.
- The study subjects provide valid observations for the biological question.
- The natural history of the disease with standard therapy, or in the absence of therapy, is known.
- The effect of the treatment is large enough to overshadow random error and bias.
- Evidence of efficacy is consistent with biological knowledge.
Controlled Clinical Trial
A controlled clinical trial contains all of the key components of a true experimental design. Treatments are assigned by design; administration of treatment and endpoint ascertainment follows a protocol. When properly designed and conducted, especially with the use of randomization and masking, the controlled clinical trial instills confidence that bias has been minimized. Replication of a controlled clinical trial, if congruent with the results of the first clinical trial, provides verification.
Observational Studies: Cohort and Case-Control Studies : Plastic and Reconstructive Surgery

- AMERICAN SOCIETY OF PLASTIC SURGEONS
- PLASTIC & RECONSTRUCTIVE SURGERY
- PRS GLOBAL OPEN
- ASPS EDUCATION NETWORK
- Subscribe to journal Subscribe
- Get new issue alerts Get alerts
- Become an ASPS Member
Secondary Logo
Journal logo.
Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.
Save my selection
Observational Studies: Cohort and Case-Control Studies
Song, Jae W. M.D.; Chung, Kevin C. M.D., M.S.
Ann Arbor, Mich.
From the Section of Plastic Surgery, Department of Surgery, University of Michigan Health System.
Received for publication January 27, 2010; accepted March 5, 2010.
Disclosure: The authors have no financial interest to declare in relation to the content of this article.
Kevin C. Chung, M.D., M.S.; Section of Plastic Surgery; University of Michigan Health System; 1500 East Medical Center Drive; 2130 Taubman Center, SPC 5340; Ann Arbor, Mich. 48109-5340; [email protected]
Summary:
Observational studies constitute an important category of study designs. To address some investigative questions in plastic surgery, randomized controlled trials are not always indicated or ethical to conduct. Instead, observational studies may be the next best method of addressing these types of questions. Well-designed observational studies have been shown to provide results similar to those of randomized controlled trials, challenging the belief that observational studies are second rate. Cohort studies and case-control studies are two primary types of observational studies that aid in evaluating associations between diseases and exposures. In this review article, the authors describe these study designs and methodologic issues, and provide examples from the plastic surgery literature.
Because of the innovative nature of the specialty, plastic surgeons are frequently confronted with a spectrum of clinical questions by patients who inquire about “best practices.” It is thus essential that plastic surgeons know how to critically appraise the literature to understand and practice evidence-based medicine and also contribute to the effort by carrying out high-quality investigations. 1 Well-designed randomized controlled trials have held the preeminent position in the hierarchy of evidence-based medicine as level I evidence ( Table 1 ). However, randomized controlled trial methodology, which was first developed for drug trials, can be difficult to conduct for surgical investigations. 2 Instead, well-designed observational studies, recognized as level II or III evidence, can play an important role in deriving evidence for plastic surgery. Results from observational studies are often criticized for being vulnerable to the influence of unpredictable confounding factors. However, recent work has challenged this notion, showing comparable results between observational studies and randomized controlled trials. 3,4 Observational studies can also complement randomized controlled trials in hypothesis generation, establishing questions for future randomized controlled trials, and defining clinical conditions.

Observational studies fall under the category of analytic study designs and are further subclassified as observational or experimental study designs ( Fig. 1 ). The goal of analytic studies is to identify and evaluate causes or risk factors of diseases or health-related events. The differentiating characteristic between observational and experimental study designs is that in the latter, the presence or absence of undergoing an intervention defines the groups. By contrast, in an observational study, the investigator does not intervene and rather simply “observes” and assesses the strength of the relationship between an exposure and disease variable. 5 Three types of observational studies include cohort studies, case-control studies, and cross-sectional studies ( Fig. 1 ). Case-control and cohort studies offer specific advantages by measuring disease occurrence and its association with an exposure by offering a temporal dimension (i.e., prospective or retrospective study design). Cross-sectional studies, also known as prevalence studies, examine the data on disease and exposure at one particular time point ( Fig. 2 ). 5 Because the temporal relationship between disease occurrence and exposure cannot be established, cross-sectional studies cannot assess the cause-and-effect relationship. In this review, we will primarily discuss cohort and case-control study designs and related methodologic issues.

COHORT STUDY
The term “cohort” is derived from the Latin word cohors . Roman legions were composed of 10 cohorts. During battle, each cohort, or military unit, consisting of a specific number of warriors and commanding centurions, were traceable. The word cohort has since been adopted into epidemiology to define a set of people followed over a period of time. W. H. Frost, an epidemiologist from the early 1900s, was the first to use the word cohort in his 1935 publication assessing age-specific mortality rates and tuberculosis. 6 The modern epidemiologic definition of the word now means a “group of people with defined characteristics who are followed up to determine incidence of, or mortality from, some specific disease, all causes of death, or some other outcome.” 6
Study Design
A well-designed cohort study can provide powerful results. In a cohort study, an outcome or disease-free study population is first identified by the exposure or event of interest and followed in time until the disease or outcome of interest occurs ( Fig. 3 , above ). Because exposure is identified before the outcome, cohort studies have a temporal framework to assess causality and thus have the potential to provide the strongest scientific evidence. 7 Advantages and disadvantages of a cohort study are listed in Table 2 . 8,9 Cohort studies are particularly advantageous for examining rare exposures because subjects are selected by their exposure status. In addition, the investigator can examine multiple outcomes simultaneously. Disadvantages include the need for a large sample size and the potentially long follow-up duration of the study design, resulting in a costly endeavor.

Cohort studies can be prospective or retrospective ( Fig. 2 ). Prospective studies are carried out from the present time into the future. Because prospective studies are designed with specific data collection methods, they have the advantage of being tailored to collect specific exposure data and may be more complete. The disadvantage of a prospective cohort study may be the long follow-up period while waiting for events or diseases to occur. Thus, this study design is inefficient for investigating diseases with long latency periods and is vulnerable to a high rate of loss to follow-up. Although prospective cohort studies are invaluable as exemplified by the landmark Framingham Heart Study, started in 1948 and still ongoing, 10 in the plastic surgery literature, this study design is generally seen to be inefficient and impractical. Instead, retrospective cohort studies are better indicated given the timeliness and inexpensive nature of the study design.
Retrospective cohort studies, also known as historical cohort studies, are carried out at the present time and look to the past to examine medical events or outcomes. In other words, a cohort of subjects selected based on exposure status is chosen at the present time, and outcome data (i.e., disease status, event status), which were measured in the past, are reconstructed for analysis. The primary disadvantage of this study design is the limited control the investigator has over data collection. The existing data may be incomplete, inaccurate, or inconsistently measured between subjects. 8 However, because of the immediate availability of the data, this study design is comparatively less costly and shorter than prospective cohort studies. For example, Spear and colleagues examined the effect of obesity and complication rates after undergoing pedicled transverse rectus abdominis musculocutaneous (TRAM) flap reconstruction by retrospectively reviewing 224 pedicled TRAM flaps in 200 patients over a 10-year period. 11 In this example, subjects who underwent pedicled TRAM flap reconstruction were selected and categorized into cohorts by their exposure status: normal/underweight, overweight, or obese. The outcomes of interest were various flap and donor-site complications. The findings revealed that obese patients had a significantly higher incidence of donor-site complications, multiple flap complications, and partial flap necrosis than normal or overweight patients. An advantage of the retrospective study design analysis is the immediate access to the data. A disadvantage is the limited control over the data collection because data were gathered retrospectively over 10 years; for example, a limitation reported by the authors is that mastectomy flap necrosis was not uniformly recorded for all subjects. 11
An important distinction lies between cohort studies and case series. The distinguishing feature between these two types of studies is the presence of a control, or unexposed, group. Contrasting with epidemiologic cohort studies, case series are descriptive studies following one small group of subjects. In essence, they are extensions of case reports. Usually, the cases are obtained from the authors' experiences, generally involve a small number of patients, and more importantly, lack a control group. 12 There is often confusion in designating studies as “cohort studies” when only one group of subjects is examined. Yet, unless a second comparative group serving as a control is present, these studies are defined as case series. The next step in strengthening an observation from a case series is selecting appropriate control groups to conduct a cohort or case-control study, the latter of which is discussed in the Case-Control Studies section later in the article. 9
Methodologic Issues
Selection of subjects in cohort studies.
The hallmark of a cohort study is defining the selected group of subjects by exposure status at the start of the investigation. A critical characteristic of subject selection is to have both the exposed and unexposed groups be selected from the same source population ( Fig. 4 ). 9 Subjects who are not at risk for developing the outcome should be excluded from the study. The source population is determined by practical considerations, such as sampling. Subjects may be effectively sampled from the hospital, be members of a community, or be from a doctor's individual practice. A subset of these subjects will be eligible for the study.

Attrition Bias (Loss to Follow-Up)
Because prospective cohort studies may require long follow-up periods, it is important to minimize loss to follow-up. Loss to follow-up is a situation in which the investigator loses contact with the subject, resulting in missing data. If too many subjects are lost to follow-up, the internal validity of the study is reduced. A general rule of thumb requires that the loss to follow-up rate not exceed 20 percent of the sample. 5 Any systematic differences related to the outcome or exposure of risk factors between those who drop out and those who stay in the study must be examined, if possible, by comparing individuals who remain in the study and those who were lost to follow-up or dropped out. It is therefore important to select subjects who can be followed for the entire duration of the cohort study. Methods of minimizing loss to follow-up are listed in Table 3 .

CASE-CONTROL STUDIES
Case-control studies were historically borne out of interest in the cause of disease. The conceptual basis of the case-control study is similar to taking a history and physical examination; the patient with disease is questioned and examined, and elements from this history taking are knitted together to reveal characteristics or factors that predisposed the patient to the disease. In fact, the practice of interviewing patients about behaviors and conditions preceding illness dates back to the Hippocratic writings of the fourth century BC . 6
Reasons of practicality and feasibility inherent in the study design typically dictate whether a cohort study or case-control study is appropriate. This study design was first recognized in Janet Lane-Claypon's study of breast cancer in 1926, revealing the finding that low fertility rates raise the risk of breast cancer. 13,14 In the ensuing decades, case-control study methodology crystallized with the landmark publication linking smoking and lung cancer in the 1950s. 15 Since that time, retrospective case-control studies have become more prominent in the biomedical literature with more rigorous methodologic advances in design, execution, and analysis.
Case-control studies identify subjects by outcome status at the outset of the investigation. Outcomes of interest may be whether the subject has undergone a specific type of surgery, experienced a complication, or been diagnosed with a disease ( Fig. 3 , below ). Once outcome status is identified and subjects are categorized as cases, controls (subjects without the outcome but from the same source population) are selected. Data regarding exposure to a risk factor or several risk factors are then collected retrospectively, typically by interview, abstraction from records, or survey. Case-control studies are well suited to investigate rare outcomes or outcomes with a long latency period because subjects are selected from the outset by their outcome status. Thus, in comparison with cohort studies, case-control studies are quick and relatively inexpensive to implement, require comparatively fewer subjects, and allow for multiple exposures or risk factors to be assessed for one outcome ( Table 4 ). 8,9

An example of a case-control investigation is the study by Zhang and colleagues, who examined the association of environmental and genetic factors associated with rare congenital microtia, 16 which has an estimated prevalence of 0.83 to 17.4 in 10,000. 17 They selected 121 congenital microtia cases based on clinical phenotype, and 152 unaffected controls, matched by age and sex in the same hospital and same period. Controls were of Han Chinese origin from Jiangsu, China, the same area from which the cases were selected. This allowed both the controls and cases to have the same genetic background, which is important to note given the investigated association between genetic factors and congenital microtia. To examine environmental factors, a questionnaire was administered to the mothers of both cases and controls. The authors concluded that adverse maternal health was among the main risk factors for congenital microtia, specifically, maternal disease during pregnancy (odds ratio, 5.89; 95 percent confidence interval, 2.36 to 14.72), maternal toxicity exposure during pregnancy (odds ratio, 4.76; 95 percent confidence interval, 1.66 to 13.68), and resident area, such as living near industries associated with air pollution (odds ratio, 7.00; 95 percent confidence interval, 2.09 to 23.47). 16 A case-control study design is most efficient for this investigation, given the rarity of the disease outcome. Because congenital microtia is thought to have multifactorial causes, an additional advantage of the case-control study design in this example is the ability to examine multiple exposures and risk factors.
Selection of Cases
Sampling in a case-control study design begins with selecting the cases. In a case-control study, it is imperative that the investigator has explicitly defined inclusion and exclusion criteria before the selection of cases. For example, if the outcome is having a disease, specific diagnostic criteria, disease subtype, stage of disease, or degree of severity should be defined. Such criteria ensure that all the cases are homogenous. Second, cases may be selected from a variety of sources, including hospital patients, clinic patients, or community subjects. Many communities maintain registries of patients with certain diseases and can serve as a valuable source of cases. However, despite the methodologic convenience of this method, validity issues may arise. For example, if cases are selected from one hospital, identified risk factors may be unique to that single hospital. This methodologic choice may weaken the generalizability of the study findings. Another example is choosing cases from the hospital versus the community; most likely, cases from the hospital sample will represent a more severe form of the disease than those in the community. 8 Finally, it is also important to select cases that are representative of cases in the target population to strengthen the study's external validity ( Fig. 4 ). Potential reasons why cases from the original target population eventually filter through and are available as cases (study participants) for a case-control study are illustrated in Figure 5 .

Selection of Controls
Selecting the appropriate group of controls can be one of the most demanding aspects of a case-control study. An important principle is that the distribution of exposure should be the same among cases and controls; in other words, both cases and controls should stem from the same source population. The investigator may also consider the control group to be an at-risk population, with the potential to develop the outcome. Because the validity of the study depends on the comparability of these two groups, cases and controls should otherwise meet the same inclusion criteria in the study.
A case-control study design that exemplifies this methodologic feature is the study by Chung and colleagues, who examined maternal cigarette smoking during pregnancy and the risk of newborns developing cleft lip–cleft palate. 18 A salient feature of this study is the use of the 1996 U.S. Natality database, a population database from which both cases and controls were selected. This database provides a large sample size to assess newborn development of cleft lip–cleft palate (outcome), which has a reported incidence of one in 1000 live births, 19 and also enabled the investigators to choose controls (i.e., healthy newborns) that were generalizable to the general population to strengthen the study's external validity. A significant relationship with maternal cigarette smoking and cleft lip–cleft palate in the newborn was reported in this study (adjusted odds ratio, 1.34; 95 percent confidence interval, 1.36 to 1.76). 18
Matching is a method used in an attempt to ensure comparability between cases and controls and reduces variability and systematic differences attributable to background variables that are not of interest to the investigator. 7 Each case is typically paired individually with a control subject with respect to the background variables. The exposure to the risk factor of interest is then compared between the cases and the controls. This matching strategy is called individual matching. Age, sex, and race are often used to match cases and controls because they are typically strong confounders of disease. 20 Confounders are variables associated with the risk factor and may potentially be a cause of the outcome. 7 Table 5 lists several advantages and disadvantages with a matching design.

Multiple Controls
Investigations examining rare outcomes may have a limited number of cases from which to select, whereas the source population from which controls can be selected is much larger. In such scenarios, the study may be able to provide more information if multiple controls per case are selected. This method increases the “statistical power” of the investigation by increasing the sample size. The precision of the findings may improve by having up to approximately three or four controls per case. 21–23
Bias in Case-Control Studies
Evaluating exposure status can be the Achilles heel of case-control studies. Because information about exposure is typically collected by self-report, interview, or from recorded information, it is susceptible to recall bias, interviewer bias, or will rely on the completeness or accuracy of recorded information, respectively. These biases decrease the internal validity of the investigation and should be carefully addressed and reduced in the study design. Recall bias occurs when a differential response between cases and controls occurs. The common scenario is when a subject with disease (case) will unconsciously recall and report an exposure with better clarity because of the disease experience. Interviewer bias occurs when the interviewer asks leading questions or has an inconsistent interview approach between cases and controls. A good study design will implement a standardized interview in a nonjudgmental atmosphere with well-trained interviewers to reduce interviewer bias. 9
THE STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY STATEMENT
In 2004, the first meeting of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) group took place in Bristol, United Kingdom. 24 The aim of the group was to establish guidelines on reporting observational research to improve the transparency of the methods, thereby facilitating the critical appraisal of a study's findings. A well-designed but poorly reported study is disadvantaged in contributing to the literature because the results and generalizability of the findings may be difficult to assess. Thus, a 22-item checklist was generated to enhance the reporting of observational studies across disciplines. 25,26 This checklist is also located at the following Web site: http://www.strobe-statement.org . This statement is applicable to cohort studies, case-control studies, and cross-sectional studies. In fact, 18 of the checklist items are common to all three types of observational studies, and four items are specific to each of the three specific study designs. In an effort to provide specific guidance to go along with this checklist, an “explanation and elaboration” article was published for users to better appreciate each item on the checklist. 27 Plastic surgery investigators should peruse this checklist before designing their study and when they are writing up the report for publication. In fact, some journals now require authors to follow the STROBE Statement. A list of participating journals can be found on this Web site: http://www.strobe-statement.org./index.php?id=strobe-endorsement .
CONCLUSIONS
Because of the limitations in carrying out randomized controlled trials in surgical investigations, observational studies are becoming more popular for investigating the relationship between exposures, such as risk factors or surgical interventions, and outcomes, such as disease states or complications. Recognizing that well-designed observational studies can provide valid results is important in the plastic surgery community, so that investigators can both critically appraise and appropriately design observational studies to address important clinical research questions. The investigator planning an observational study can certainly use the STROBE statement as a tool to outline key features of a study and come back to it again at the end to enhance transparency in methodology reporting.
ACKNOWLEDGMENT
This work was supported in part by a Midcareer Investigator Award in Patient-Oriented Research (K24 AR053120) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (to K.C.C.).
- Cited Here |
- View Full Text | PubMed | CrossRef
- PubMed | CrossRef
- + Favorites
- View in Gallery

Want to Write a Field Study Report? 6 Key Points to Consider!

Research conduction is not just limited to your laboratory, library, or work place setting. As part of your research you may have to step out in the field (any place other than your regular research lab or work station) to collect raw data for analysis and then publish it as a field study report. In this article, we will discuss the elements of a field study report and the key points to consider while writing one!
Table of Contents
What is a Field Study Report?
A field study report is defined as a documentation of analysis of particular phenomena, behaviors, processes based on theories and observations made by the researcher in the field. These observed and analyzed theories are used to identify solutions for a specific project or case report .
What is the Importance of Field Study Report?
- A field study report is important as part of many operational and technical documentation processes in various industries including field services, education, medicine, and management.
- Moreover, it gives detailed information of an observed subject or specimen which is used to analyze and compare data against a theoretical framework .
- It also helps in identifying challenges in implementing solutions to form a standardized protocol.
- Furthermore, it helps in capturing information on resource management and discovering new processes for effective and optimized solutions.
How to Write Field Research Notes?
A field study report begins with an idea and ends with a solution. Hence, while conducting field research, one must follow a planned route of taking notes for proper documentation of the observations made. A successful field study report begins when the researcher is involved in the observational research process of taking proper notes.
Based on the methods, the field research notes are categorized in four different types:
1. Job Notes:
- Researchers use this method of taking field notes whilst they are conducting the study.
- These notes are taken in close proximity and in open sight with the study’s subject.
- These notes are brief, concise, in the form that can be built on by the researcher later while creating the report.
2. Field Notes Proper:
- This method of taking field notes is to expand them immediately after the completion of study.
- These notes are detailed and the words have to be as close to the terms that will be used in the final field study report.
3. Methodological Notes:
- This type of field notes involve research methods used by the researcher, newly proposed research methods, and the way to monitor their progress.
- Methodological notes are either attached with field notes or filed separately. These notes are always placed at the end of the field study report.
4. Journals and Diaries:
- This method of taking notes is an insight into the researcher’s life as it tracks all aspects of the researcher’s life.
- It helps in eliminating any bias that may have affected the field research.
Examples of Things to Document During Field Study
1. Physical Setting:
Observe the characteristics of the space where the study is being conducted.
2. Objects and Material:
The presence, placement, and arrangement of objects that affect the behavior of the subject being studied.
3. Language Used:
Observe the language being used by study participants (in case of human participation).
4. Behavior Cycles:
Document who is performing what behavior at what time and situation.
5. Physical Characteristics of Participants/Subjects:
Observe and note personal characteristics of subjects.
6. Body Movements:
Things such as body posture or facial expressions and assess if these movements support or contradict the language used while communicating.
Data Collection in Field Report (Sampling Techniques)
Data collection process in field study is also known as sampling. It refers to the process used to select a portion of the population for study. Selection of an ideal sampling technique is imperative to obtain the richest possible source of information to answer the research questions.
Different Types of Sampling Techniques:
Ad Libitum Sampling
This technique involves observing whatever seems interesting at the moment. It does not follow an organized system of recording the observations.
Behavior Sampling
This sampling technique involves watching the entire group of subjects and recording each occurrence of a specific behavior of interest with reference to which individuals were involved.
Continuous Recording
This sampling technique includes recording of frequencies, durations, and latencies in a continuous and systematic pattern.
Focal Sampling
The focal sampling technique involves observing one individual/subject for a specified amount of time and recording all instances of that individual’s behavior.
Instantaneous Sampling
The technique of instantaneous sampling involves dividing observation sessions into short intervals by sample points.
One-Zero Sampling
The one-zero sampling technique is similar to instantaneous sampling. It involves recording only if the behaviors of interest have occurred at any time during an interval instead of at the instant of the sampling point.
Scan Sampling
The scan sampling technique involves taking a census of the entire observed group at predetermined time periods and recording what each individual is doing at that moment.
What is the Structure and Writing Style of Field Study Report?
A field study report does not have a standard format; however, the following factors determined its structure and writing style:
- Nature of research problem
- Theoretical perspective that drives the analysis
- Observations made by researcher
- Specific guidelines established by your professor/supervisor
A field study report includes 6 main elements as follows:
1. Introduction
The introduction section should describe the objective and important theories or concepts underpinning your field study. More importantly, it should describe the organization’s nature or setting where you are conducting the observation—the types of observations conducted, the focus of your research study, what was observed, and which methods were used for collecting the data. Furthermore, it is important to include a review of pertinent literature .
2. Description of Activities
It becomes imperative for researchers to provide the information to the readers about what happened during the field study. Hence, you must include the details of all events that take place during your field research.
The description section helps in answering the five “WH” questions as mentioned below:
What did you see and hear in your area of study?
Where does the background information of the research setting is observed and reported?
Why are you conducting this field research?,
The reason behind particular thing happening , and
Why have you included or excluded specific information?
Who are the participants in terms of gender, age, ethnicity, and other relevant variables from your observation?
When is the study being conducted (day or time when occurring actions are observed and noted)?
3. Analysis and Interpretation
While you are on the field conducting the study, you are likely to observe multiple things. However, it is up to you as to which observations do you want to interpret and record in the report. This allows you to show the reader that you are interpreting events like an informed observer. Furthermore, your theoretical framework helps you in making this decision. The analysis and interpretation of your field observations must always be placed in the larger context of the theories described in the introduction.
Some questions to ask yourself when analyzing your observations are as follows:
- What is the meaning of your observations?
- What are the reasons behind the occurrence of the things you observed?
- How typical or widespread are the events and behaviors of the things you observed?
- Are there any connections or patterns in your observations?
- What are the implications of your observations?
- Did your observations match the objective of your study?
- What were the merits of your observations?
- What were the strengths and weaknesses of your recorded observations?
- Are there any connections between your findings and the findings from pertinent literature?
- Do your observations fit into the larger context of the study’s theories?
4. Conclusion and Recommendations
The conclusion of your field study report should summarize your report and emphasize the importance of your observations. This section has to be concise and relevant to your field study and must not include any new information. Furthermore, it is imperative to highlight any recommendations that you may have for readers to consider while conducting similar study. Additionally, describe any unanticipated problems you encountered and note the limitations of your study. Limit your conclusion to around two to three paragraphs.
5. References
The reference section must include every source that you referred to and used while writing your field study report. Since format for writing references may differ for every university, you must consult your professor to understand the format and write it accordingly.
6. Appendix
This section includes information that is not essential to explain your findings, but supports your analysis [especially repetitive or lengthy information]. It validates your conclusions and contextualize a related point. This helps the reader to understand the overall field study report.
6 Key Points to Consider While Writing a Field Study Report
A field study report focuses on factual and observational details of a project case. It must help the reader understand how theory applies to real-world scenarios. Hence, it should cover the circumstances and contributing factors to derive conclusive results from the observed and collated raw data.
Below are the key points to consider while writing a field study report:

1. Define the Objective of Your Field Report
- Ensure that you state the purpose of your field study report clearly.
- Determine the focus of your study and provide the relevant information.
- Define the setting of observations, and the methods used to collect data.
2. Construct a Theoretical Framework
- Creating a theoretical framework helps you in garnering information based on statistics, news, and pertinent literature for better understanding.
- Additionally, it guides you in determining the data that need to be analyzed and set as a baseline for comparison to acquire necessary information.
3. Record Study Observations and Analysis
- Take notes of your observations based on the defined scope of work (SOW).
- Furthermore, achieve and record the detailed plan on how to achieve the set objectives.
4. Include Photo Evidence of Observed Items
- Validate gathered raw data with photographs or videos as evidences.
- This increases the authenticity of your report and the conclusions you derive from it.
5. Record Overall Assessment and Recommendations
- Document all the observed aspects of your study based on gathered analysis and observations.
- Furthermore, clearly explain the observations and discuss the challenges and limitations faced by you while conducting the study.
6. Validate the Observations with a Signature
- After completing your research and documenting it, it is important to declare who is responsible for the reported data.
- Additionally, you must validate your findings in the field study report by signing off with a digital signature at the end of the report.
Did you every try writing a field study report? How difficult or easy was it? What methods do you follow while writing a field report? Let us know about it in the comments section below!

very well written….the enumeration is really commendable dear Bhosale…sweet regards from Nepal..
Very well explained and detailed. The information was relevant to my research. thanks
Rate this article Cancel Reply
Your email address will not be published.

Enago Academy's Most Popular

- Manuscript Preparation
- Publishing Research
- Reporting Research
Research Problem Statement — Find out how to write an impactful one!
What Is a Research Problem Statement? A research problem statement is a clear, concise, and…

- Industry News
- Publishing News
2022 in a Nutshell — Reminiscing the year when opportunities were seized and feats were achieved!
It’s beginning to look a lot like success! Some of the greatest opportunities to research…
- Old Webinars
- Webinar Mobile App
A Comprehensive Series on Clinical Research Writing: Part I — Protocol Writing
Importance of research protocol How to structure a research protocol Common pitfalls to avoid

- Selecting Journals
Multiple Submissions to One Journal — How will it affect my academic reputation?
The journal editors were in a bind. There’s a flux of new submissions and each…

Writing Limitations of Research Study — 4 Reasons Why It Is Important!
It is not unusual for researchers to come across the term limitations of research during…
2022 in a Nutshell — Reminiscing the year when opportunities were seized and feats…
Write an Error-free Research Protocol As Recommended by WHO: 21 Elements You…
5 Tips to Write Scientific Article When You Lack Motivation
Sign-up to read more
Subscribe for free to get unrestricted access to all our resources on research writing and academic publishing including:
- 2000+ blog articles
- 50+ Webinars
- 10+ Expert podcasts
- 50+ Infographics
- 10+ Checklists
- Research Guides
We hate spam too. We promise to protect your privacy and never spam you.
I am looking for Editing/ Proofreading services for my manuscript Tentative date of next journal submission:

For what are you most likely to depend on AI-assistance?
- Open supplemental data
- Reference Manager
- Simple TEXT file
People also looked at
Study protocol article, a protocol for the use of case reports/studies and case series in systematic reviews for clinical toxicology.
- 1 Univ Angers, CHU Angers, Univ Rennes, INSERM, EHESP, Institut de Recherche en Santé, Environnement et Travail-UMR_S 1085, Angers, France
- 2 Department of Occupational Medicine, Epidemiology and Prevention, Donald and Barbara Zucker School of Medicine, Northwell Health, Feinstein Institutes for Medical Research, Hofstra University, Great Neck, NY, United States
- 3 Department of Health Sciences, University of California, San Francisco and California State University, Hayward, CA, United States
- 4 Program on Reproductive Health and the Environment, University of California, San Francisco, San Francisco, CA, United States
- 5 Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy
- 6 Department of Research and Public Health, Reims Teaching Hospitals, Robert Debré Hospital, Reims, France
- 7 CHU Angers, Univ Angers, Poisoning Control Center, Clinical Data Center, Angers, France
Introduction: Systematic reviews are routinely used to synthesize current science and evaluate the evidential strength and quality of resulting recommendations. For specific events, such as rare acute poisonings or preliminary reports of new drugs, we posit that case reports/studies and case series (human subjects research with no control group) may provide important evidence for systematic reviews. Our aim, therefore, is to present a protocol that uses rigorous selection criteria, to distinguish high quality case reports/studies and case series for inclusion in systematic reviews.
Methods: This protocol will adapt the existing Navigation Guide methodology for specific inclusion of case studies. The usual procedure for systematic reviews will be followed. Case reports/studies and case series will be specified in the search strategy and included in separate sections. Data from these sources will be extracted and where possible, quantitatively synthesized. Criteria for integrating cases reports/studies and case series into the overall body of evidence are that these studies will need to be well-documented, scientifically rigorous, and follow ethical practices. The instructions and standards for evaluating risk of bias will be based on the Navigation Guide. The risk of bias, quality of evidence and the strength of recommendations will be assessed by two independent review teams that are blinded to each other.
Conclusion: This is a protocol specified for systematic reviews that use case reports/studies and case series to evaluate the quality of evidence and strength of recommendations in disciplines like clinical toxicology, where case reports/studies are the norm.
Introduction
Systematic reviews are routinely relied upon to qualitatively synthesize current knowledge in a subject area. These reviews are often paired with a meta-analysis for quantitative syntheses. These qualitative and quantitative summaries of pooled data, collectively evaluate the quality of the evidence and the strength of the resulting research recommendations.
There currently exist several guidance documents to instruct on the rigors of systematic review methodology: (i) the Cochrane Collaboration, Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and PRISMA-P (for protocols) that offer directives on data synthesis; and (ii) the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines that establish rules for the development of scientific recommendations ( 1 – 5 ). This systematic review guidance is based predominantly on clinical studies, where randomized controlled trials (RCTs) are the gold standard. For that reason, a separate group of researchers has designed the Navigation Guide, specific to environmental health studies that are often observational ( 6 , 7 ). To date, systematic review guidelines (GRADE, PRISMA, PRISMA-P, and Navigation Guide) remove case reports/studies and case series (human subjects research with no control group) from consideration in systematic reviews, in part due to the challenges in evaluating the internal validity of these kinds of study designs. We hypothesize, however, that under certain circumstances, such as in rare acute poisonings, or preliminary reports of new drugs, some case reports and case series may contribute relevant knowledge that would be informative to systematic review recommendations. This is particularly important in clinical settings, where such evidence could potentially change our understanding of the screening, presentation, and potential treatment of rare conditions, such as poisoning from obscure toxins. The Cochrane Collaboration handbook states that “ for some rare or delayed adverse outcomes only case series or case-control studies may be available. Non-randomized studies of interventions with some study design features that are more susceptible to bias may be acceptable for evaluation of serious adverse events in the absence of better evidence, but the risk of bias must still be assessed and reported ” ( 8 ). In addition, the Cochrane Adverse Effects group has shown that case studies may be the best settings in which to observe adverse effects, especially when they are rare and acute ( 9 ). We believe that there may be an effective way to consider case reports/studies and case series in systematic reviews, specifically by developing specific criteria for their inclusion and accounting for their inherent bias.
We propose here a systematic review protocol that has been specifically developed to consider the inclusion and integration of case reports/studies and case series. Our main objective is to create a protocol that is an adaptation of the Navigation Guide ( 6 , 10 ) that presents methodology to examine high quality case reports/studies and case series through cogent inclusion and exclusion criteria. This methodology is in concordance with the Cochrane Methods for Adverse Effects for scoping reviews ( 11 ).
This protocol was prepared in accordance with the usual structured methodology for systematic reviews (PRISMA, PRISMA-P, and Navigation guide) ( 3 – 7 , 10 ). The protocol will be registered on an appropriate website, such as one of the following:
(i) The International Prospective Register of Systematic Reviews (PROSPERO) database ( https://www.crd.york.ac.uk/PROSPERO/ ) is an international database of prospectively registered systematic reviews in health and social welfare, public health, education, crime, justice, and international development, where there is a health-related outcome. It aims to provide a comprehensive listing of systematic reviews registered at inception to help avoid duplication and reduce opportunity for reporting bias by enabling comparison of the completed review with what was planned in the protocol. PROSPERO accepts registrations for systematic reviews, rapid reviews, and umbrella reviews. Key elements of the review protocol are permanently recorded and stored.
(ii) The Open Science Framework (OSF) platform ( https://osf.io/ ) is a free, open, and integrated platform that facilitates open collaboration in research science. It allows for the management and sharing of research project at all stages of research for broad dissemination. It also enables capture of different aspects and products of the research lifecycle, from the development of a research idea, through the design of a study, the storage and analysis of collected data, to the writing and publication of reports or research articles.
(iii) The Research Registry (RR) database ( https://www.researchregistry.com/ ) is a one-stop repository for the registration of all types of research studies, from “first-in-man” case reports/studies to observational/interventional studies to systematic reviews and meta-analyses. The goal is to ensure that every study involving human participants is registered in accordance with the 2013 Declaration of Helsinki. The RR enables prospective or retrospective registrations of studies, including those types of studies that cannot be registered in existing registries. It specifically publishes systematic reviews and meta-analyses and does not register case reports/studies that are not first-in-man or animal studies.
Any significant future changes to the protocol resulting from knowledge gained during the development stages of this project will be documented in detail and a rationale for all changes will be proposed and reported in PROSPERO, OSF, or RR.
The overall protocol will differentiate itself from other known methodologies, by defining two independent teams of reviewers: a classical team and a case team. The classical team will review studies with control groups and an acceptable comparison group (case reports/studies and case series will be excluded). In effect, this team will conduct a more traditional systematic review where evidence from case reports/studies and case series are not considered. The case team will review classical studies, case reports, and case series. This case team will act as a comparison group to identify differences in systematic review conclusions due to the inclusion of evidence from case reports/studies and case series. Both teams will identify studies that meet specified inclusion criteria, conduct separate analyses and risk of bias evaluations, along with overall quality assessments, and syntheses of strengths of evidence. Each team will be blinded to the results of the other team throughout the process. Upon completion of the systematic review, results from each team will be presented, evaluated, and compared.
Patient and Public Involvement
No patient involved.
Eligibility Criteria
Studies will be selected according to the criteria outlined below.
Study Designs
Studies of any design reported in any translatable language to English by online programs (e.g., Google Translate) will be included at the beginning. These studies will span interventional studies with control groups (Randomized Controlled Trials: RCTs), as well as observational studies with and without exposed groups. All observational studies will be eligible for inclusion in accordance with the objectives of this systematic review. Thereafter, only the case team will include cases reports/studies and case series, as specified in their search strategy. The case team will include a separate section for human subjects research that has been conducted with no control groups.
Type of Population
All types of studies examining the general adult human population or healthy adult humans will be included. Studies that involve both adults and children will also be included if data for adults are reported separately. Animal studies will be excluded for the methodological purpose of this (case reports/studies and case series) protocol given that the framework for systematic reviews in toxicology already adequately retrieves this type of toxin data on animals.
Inclusion/Exclusion Criteria
Studies of any design will be included if they fulfill all the eligibility criteria. To be integrated into the overall body of evidence, cases reports/studies and case series must meet pre-defined criteria indicating that they are well-documented, scientifically rigorous, and follow ethical practices, under the CARE guidelines (for Ca se Re ports) ( 12 , 13 ) and the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Case reports/studies and for Case Series ( 14 , 15 ) that classify case reports/studies in terms of completeness, transparency and data analysis. Studies that were conducted using unethical practices will be excluded.
Type of Exposure/Intervention
Either the prescribed treatment or described exposure to a chemical substance (toxin/toxicant) will be detailed here.
Type of Comparators
In this protocol we plan to compare two review methodologies: one will include and the other will exclude high quality case reports/studies and case series; these two review methodologies will be compared. The comparator will be (the presence or absence of) an available control group that has been specified and is acceptable scientifically and ethically.
Type of Outcomes
The outcome of mortality or morbidity related to the toxicological exposure, will be detailed here.
Information Sources and Search Strategy
There will be no design, date or language limitations applied to the search strategy. A systematic search in electronic academic databases, electronic grey literature, organizational websites, and internet search engines will be performed. We will search at least the following major databases:
- Electronic academic databases : Pubmed, Web of Sciences, Toxline, Poisondex, and databases specific to case reports/studies and case series (e.g., PMC, Scopus, Medline) ( 13 )
- Electronic grey literature databases : OpenGrey ( http://www.opengrey.eu/ ), grey literature Report ( http://greylit.org/ )
- Organizational websites : AHRQ Patient Safety Network ( https://psnet.ahrq.gov/webmm ), World Health Organization ( www.who.int )
- Internet search engines : Google ( https://www.google.com/ ), GoogleScholar ( https://scholar.google.com/ ).
Study Records
Following a systematic search in all the databases above, each of the two independent teams of reviewers (the classical team and the case team) will, respectively, upload separately and in accordance with the eligibility criteria, the literature search results to the systematic review management software, “Covidence,” a primary screening and data extraction tool ( 16 ).
All study records identified during the search will be downloaded and duplicate records will be identified and deleted. Thereafter, two research team members will independently screen the titles and abstracts (step 1) and then the full texts (step 2) of potentially relevant studies for inclusion. If necessary, information will be requested from the publication authors to resolve questions about eligibility. Finally, any disagreements that may potentially exist between the two research team members will be resolved first by discussion and then by consulting a third research team member for arbitration.
If a study record identified during the search was authored by a reviewing research team member, or that team member participated in the identified study, that study record will be re-assigned to another reviewing team member.
Data Collection Process, Items Included, and Prioritization if Needed
All reviewing team members will use standardized forms or software (e.g., Covidence), and each review member will independently extract the data from included studies. If possible, the extracted data will be synthesized numerically. To ensure consistency across reviewers, calibration exercises (reviewer training) will be conducted prior to starting the reviews. Extracted information will include the minimum study characteristics (study authors, study year, study country, participants, intervention/exposure, outcome), study design (summary of study design, comparator, models used, and effect estimate measure) and study context (e.g., data on simultaneous exposure to other risk factors that would be relevant contributors to morbidity or mortality). As specified in the section on study records, a third review team member will resolve any conflicts that arise during data extraction that are not resolved by consensus between the two initial data extractors.
Data on potential conflict of interest for included studies, as well as financial disclosures and funding sources, will also be extracted. If no financial statement or conflict of interest declaration is available, the names of the authors will be searched in other studies published within the previous 36 months and in other publicly available declarations of interests, for funding information ( 17 , 18 ).
Risk of Bias Assessment
To assess the risk of bias within included studies, the internal validity of potential studies will be assessed by using the Navigation Guide tool ( 6 , 19 ), which covers nine domains of bias for human studies: (a) source population representation; (b) blinding; (c) exposure or intervention assessment; (d) outcome assessment; (e) confounding; (f) incomplete outcome data; (g) selective outcome reporting; (h) conflict of interest; and (i) other sources of bias. For each section of the tool, the procedures undertaken for each study will be described and the risk of bias will be rated as “ low risk”; “probably low risk”; “probably risk”; “high risk”; or “not applicable.” Risk of bias on the levels of the individual study and the entire body of evidence will be assessed. Most of the text from these instructions and criteria for judging risk of bias has been adopted verbatim or adapted from one of the latest Navigation Guide systematic reviews used by WHO/ILO ( 6 , 19 , 20 ).
For case reports/studies and case series, the text from these instructions and criteria for judging risk of bias has been adopted verbatim or adapted from one of the latest Navigation Guide systematic reviews ( 21 ), and is given in Supplementary Material . Specific criteria are listed below. To ensure consistency across reviewers, calibration exercises (reviewer training) will be conducted prior to starting the risk of bias assessments for case reports/studies and case series.
Are the Study Groups at Risk of Not Representing Their Source Populations in a Manner That Might Introduce Selection Bias?
The source population is viewed as the population for which study investigators are targeting their study question of interest.
Examples of considerations for this risk of bias domain include: (1) the context of the case report; (2) level of detail reported for participant inclusion/exclusion (including details from previously published papers referenced in the article), with inclusion of all relevant consecutive patients in the considered period; ( 14 , 15 ) (3) exclusion rates, attrition rates and reasons.

Were Exposure/Intervention (Toxic, Treatment) Assessment Methods Lacking Accuracy?
The following list of considerations represents a collection of factors proposed by experts in various fields that may potentially influence the internal validity of the exposure assessment in a systematic manner (not those that may randomly affect overall study results). These should be interpreted only as suggested considerations and should not be viewed as scoring or a checklist . Considering there are no controls in such designs, this should be evaluated carefully to be sure the report really contributes to the actual knowledge .
List of Considerations :
Possible sources of exposure assessment metrics:
1) Identification of the exposure
2) Dose evaluation
3) Toxicological values
4) Clinical effects *
5) Biological effects *
6) Treatments given (dose, timing, route)
* Some clinical and biological effects might be related to exposure
For each, overall considerations include:
1) What is the quality of the source of the metric being used?
2) Is the exposure measured in the study a surrogate for the exposure?
3) What was the temporal coverage (i.e., short or long-term exposure)?
4) Did the analysis account for prediction uncertainty?
5) How was missing data accounted for, and any data imputations incorporated?
6) Were sensitivity analyses performed?
Were Outcome Assessment Methods Lacking Accuracy?
This item is similar to actual Navigation guidelines that require an assessment of the accuracy of the measured outcome.
Was Potential Confounding Inadequately Incorporated?
This is a very important issue for case reports/studies and case series. Case reports/studies and case series do not include controls and so, to be considered in a systematic review, these types of studies will need to be well-documented with respect to treatment or other contextual factors that may explain or influence the outcome. Prior to initiating the study screening, review team members should collectively generate a list of potential confounders that are based on expert opinion and knowledge gathered from the scientific literature:
Tier I: Important confounders
• Other associated treatment (i.e., intoxication, insufficient dose, history, or context)
• Medical history
Tier II: Other potentially important confounders and effect modifiers:
• Age, sex, country.
Were Incomplete Outcome Data Inadequately Addressed?
This item is similar to actual Navigation Guide instructions, though it may be very unlikely that outcome data would be incomplete in published case reports/studies and case series.
Does the Study Report Appear to Have Selective Outcome Reporting?
This item is similar to actual Navigation Guide instructions, though it may be very unlikely that there would be selective outcome reporting in published case reports/studies and case series.
Did the Study Receive Any Support From a Company, Study Author, or Other Entity Having a Financial Interest?
This item is similar to actual Navigation Guide instructions.
Did the Study Appear to Have Other Problems That Could Put It at a Risk of Bias?
Data synthesis criteria and summary measures if feasible.
Meta-analyses will be conducted using a random-effects model if studies are sufficiently homogeneous in terms of design and comparator. For dichotomous outcomes, effects of associations will be determined by using risk ratios (RR) or odds ratios (OR) with 95% confidence intervals (CI). Continuous outcomes will be analyzed using weighted mean differences (with 95% CI) or standardized mean differences (with 95% CI) if different measurement scales are used. Skewed data and non-quantitative data will be presented descriptively. Where data are missing, a request will be made to the original authors of the study to obtain the relevant missing data. If these data cannot be obtained, an imputation method will be performed. The statistical heterogeneity of the studies using the Chi Squared test (significance level: 0.1) and I 2 statistic (0–40%: might not be important; 30–60%: may represent moderate heterogeneity; 50–90%: may represent substantial heterogeneity; 75–100%: considerable heterogeneity). If there is heterogeneity, an attempt will be made to explain the source of this heterogeneity through a subgroup or sensitivity analysis.
Finally, the meta-analysis will be conducted in the latest version of the statistical software RevMan. The Mantel-Haenszel method will be used for the fixed effects model if tests of heterogeneity are not significant. If statistical heterogeneity is observed ( I 2 ≥ 50% or p < 0.1), the random effects model will be chosen. If quantitative synthesis is not feasible (e.g., if heterogeneity exists), a meta-analysis will not be performed and a narrative, qualitative summary of the study findings will be done.
Separate analyses will be conducted for the studies that contain control groups using expected mortality/morbidity, in order to include them in the quantitative synthesis of case reports/studies and case series.
If quantitative synthesis is not appropriate, a systematic narrative synthesis will be provided with information presented in the text and tables to summarize and explain the characteristics and findings of the included studies. The narrative synthesis will explore the relationship and findings both within and between the included studies.
Possible Additional Analyses
If feasible, subgroup analyses will be used to explore possible sources of heterogeneity, if there is evidence for differences in effect estimates by country, study design, or patient characteristics (e.g., sex and age). In addition, sensitivity analysis will be performed to explore the source of heterogeneity as for example, published vs. unpublished data, full-text publications vs. abstracts, risk of bias (by omitting studies that are judged to be at high risk of bias).
Overall Quality of Evidence Assessment
The quality of evidence will be assessed using an adapted version of the Evidence Quality Assessment Tool in the Navigation Guide. This tool is based on the GRADE approach ( 1 ). The assessment will be conducted by two teams, again blinded to each other, one that has the results of the case reports/studies and case series/control synthesis, the other without.
Data synthesis will be conducted independently by the classical and case teams. Evidence ratings will start at “high” for randomized control studies, “moderate” for observational studies, and “low” for case reports/studies and case series . It is important to be clear that sufficient levels of evidence cannot be achieved without study comparators. With regards to case reports/studies and case series, we classify these as starting at the lowest point of evidence and therefore we cannot consider evidence higher than low for these kinds of studies. Complete instructions for making quality of evidence judgments are presented in Supplementary Material .
Synthesis of Strength of Evidence
The standard Navigation Guide methodology will be applied to rate the strength of recommendations. The classical and case teams, blinded to the results from each other during the process, will independently assess the strength of evidence. The evidence quality ratings will be translated into strength of evidence for each population based on a combination of four criteria: (a) Quality of body of evidence; (b) Direction of effect; (c) Confidence in effect; and (d) Other compelling attributes of the data that may influence certainty. The ratings for strength of evidence will be “sufficient evidence of harmfulness,” “limited of harmfulness,” “inadequate of harmfulness” and “evidence of lack of harmfulness.”
Once we complete the synthesis of case reports/studies and case series, findings of this separate evidence stream will only be considered if RCTs and observational studies are not available. They will not be used to upgrade or downgrade the strength of other evidence streams.
To the best of our knowledge, this protocol is one of the first to specifically address the incorporation of case reports/studies and case series in a systematic review ( 9 ). The protocol was adapted from the Navigation Guide with the intent of integrating the case reports/studies and case series in systematic review recommendations, while following traditional systematic review methodology to the greatest extent possible. To be included, these case report/studies and case series will need to be well-documented, scientifically rigorous, and follow ethical practices. In addition, we believe that some case reports/studies and case series might bring relevant knowledge that should be considered in systematic review recommendations when data from RCT's and observational studies are not available, especially when even a small number of studies report an important and possibly causal association in an epidemic or a side effect of a newly marketed medicine. Our methodology will be the first to effectively incorporate case reports/studies and case series in systematic reviews that synthesize evidence for clinicians, researchers, and drug developers. These types of studies will be incorporated mostly through paper selection and risk of bias assessments. In addition, we will conduct meta-analyses if the eligible studies provide sufficient data.
This protocol has limitations related primarily to the constraints of case reports/studies and case series. These are descriptive studies. In addition, a case series is subject to selection bias because the clinician or researcher selects the cases themselves and may represent outliers in clinical practice. Furthermore, this kind of study does not have a control group, so it is not possible to compare what happens to other people who do not have the disease or receive treatment. These sources of bias mean that reported results may not be generalizable to a larger patient population and therefore cannot generate information on incidences or prevalence rates and ratios ( 22 , 23 ). However, it is important to note that promoting the need to synthesize these types of studies (case reports/studies and case series) in a formal systematic review, should not deter or delay immediate action from being taken when a few small studies report a plausible causal association between exposure and disease, such as, in the event of an epidemic or a side effect of a newly marketed medicine ( 23 ). In this study protocol, we will not consider animal studies that might give relevant toxicological information because we are focusing on study areas where a paucity of information exists. Finally, we must note that, case reports/studies and case series do not provide independent proof, and therefore, the findings of this separate evidence stream (case reports/studies and case series) will only be considered if evidence from RCTs and observational studies is not available. Case reports/studies and case series will not be used to upgrade or downgrade the strength of other evidence streams. In any case, it is very important to remember that these kinds of studies (case reports/studies and case series) are there to quickly alert agencies of the need to take immediate action to prevent further harm.
Despite these limitations, case reports/studies and case series are a first line of evidence because they are where new issues and ideas emerge (hypothesis-generating) and can contribute to a change in clinical practice ( 23 – 25 ). We therefore believe that data from case reports/studies and case series, when synthesized and presented with completeness and transparency, may provide important details that are relevant to systematic review recommendations.
Author Contributions
AD and GS the protocol study was designed. JL, TW, and DM reviewed. MF, ALG, RV, NC, CB, GLR, MD, ML, and AN significant improvement was made. AN and AD wrote the manuscript. GS improved the language. All authors reviewed and commented on the final manuscript, read and approved the final manuscript to be published.
This project was supported by the French Pays de la Loire region and Angers Loire Métropole, University of Angers and Centre Hospitalo-Universitaire CHU Angers. The project is entitled TEC-TOP (no award/grant number).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2021.708380/full#supplementary-material
1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. (2008) 336:924–6. doi: 10.1136/bmj.39489.470347.AD
PubMed Abstract | CrossRef Full Text | Google Scholar
2. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020) . Cochrane (2020). Available online at: www.training.cochrane.org/handbook
Google Scholar
3. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. (2009) 62:e1–34. doi: 10.1016/j.jclinepi.2009.06.006
4. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. (2015) 4:1. doi: 10.1186/2046-4053-4-1
5. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 : elaboration and explanation. BMJ . (2015) 350:g7647. doi: 10.1136/bmj.g7647
PubMed Abstract | CrossRef Full Text
6. Woodruff TJ, Sutton P, Navigation Guide Work Group. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Aff (Millwood). (2011) 30:931–7. doi: 10.1377/hlthaff.2010.1219
7. Woodruff TJ, Sutton P. The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes. Environ Health Perspect. (2014) 122:1007–14. doi: 10.1289/ehp.1307175
8. Reeves BC, Deeks JJ, Higgins JPT, Shea B, Tugwell P, Wells GA. Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane (2020). Available online at: www.training.cochrane.org/handbook
9. Loke YK, Price D, Herxheimer A, the Cochrane Adverse Effects Methods Group. Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol. (2007) 7:32. doi: 10.1186/1471-2288-7-32
10. Lam J, Koustas E, Sutton P, Johnson PI, Atchley DS, Sen S, et al. The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. Environ Health Perspect. (2014) 122:1040–51. doi: 10.1289/ehp.1307923
11. Peryer G, Golder S, Junqueira DR, Vohra S, Loke YK. Chapter 19: Adverse effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020) . Cochrane (2020). Available online at: www.training.cochrane.org/handbook
12. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. (2013) 7:223. doi: 10.1186/1752-1947-7-223
13. Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. (2017) 89:218–35. doi: 10.1016/j.jclinepi.2017.04.026
14. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI (2020). doi: 10.46658/JBIMES-20-08. Available online at: https://synthesismanual.jbi.global
CrossRef Full Text
15. Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evidence Synthesis. (2020) 18:2127–33. doi: 10.11124/JBISRIR-D-19-00099
16. Covidence systematic review software, V.H.I. Covidence Systematic Review Software , V.H.I. Melbourne, CA. Available online at: www.covidence.org ; https://support.covidence.org/help/how-can-i-cite-covidence
17. Drazen JM, de Leeuw PW, Laine C, Mulrow C, DeAngelis CD, Frizelle FA, et al. Toward More Uniform Conflict Disclosures: The Updated ICMJE Conflict of Interest Reporting Form. JAMA. (2010) 304:212. doi: 10.1001/jama.2010.918
18. Drazen JM, Weyden MBVD, Sahni P, Rosenberg J, Marusic A, Laine C, et al. Uniform Format for Disclosure of Competing Interests in ICMJE Journals. N Engl J Med. (2009) 361:1896–7. doi: 10.1056/NEJMe0909052
19. Johnson PI, Sutton P, Atchley DS, Koustas E, Lam J, Sen S, et al. The navigation guide—evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect. (2014) 122:1028–39. doi: 10.1289/ehp.1307893
20. Descatha A, Sembajwe G, Baer M, Boccuni F, Di Tecco C, Duret C, et al. WHO/ILO work-related burden of disease and injury: protocol for systematic reviews of exposure to long working hours and of the effect of exposure to long working hours on stroke. Environ Int. (2018) 119:366–78. doi: 10.1016/j.envint.2018.06.016
21. Lam J, Lanphear BP, Bellinger D, Axelrad DA, McPartland J, Sutton P, et al. Developmental PBDE exposure and IQ/ADHD in childhood: a systematic review and meta-analysis. Environ Health Perspect. (2017) 125:086001. doi: 10.1289/EHP1632
22. Hay JE, Wiesner RH, Shorter RG, LaRusso NF, Baldus WP. Primary sclerosing cholangitis and celiac disease. Ann Intern Med. (1988) 109:713–7. doi: 10.7326/0003-4819-109-9-713
23. Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. (2014) 7:264. doi: 10.1186/1756-0500-7-264
24. Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis. (2013) 13:78. doi: 10.1186/1471-2334-13-78
25. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, et al. Clinical Practice Guidelines We Can Trust . Washington, D.C.: National Academies Press (2011).
Keywords: toxicology, epidemiology, public health, protocol, systematic review, case reports/studies, case series
Citation: Nambiema A, Sembajwe G, Lam J, Woodruff T, Mandrioli D, Chartres N, Fadel M, Le Guillou A, Valter R, Deguigne M, Legeay M, Bruneau C, Le Roux G and Descatha A (2021) A Protocol for the Use of Case Reports/Studies and Case Series in Systematic Reviews for Clinical Toxicology. Front. Med. 8:708380. doi: 10.3389/fmed.2021.708380
Received: 19 May 2021; Accepted: 11 August 2021; Published: 06 September 2021.
Reviewed by:
Copyright © 2021 Nambiema, Sembajwe, Lam, Woodruff, Mandrioli, Chartres, Fadel, Le Guillou, Valter, Deguigne, Legeay, Bruneau, Le Roux and Descatha. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Aboubakari Nambiema, aboubakari.nambiema@univ-angers.fr ; orcid.org/0000-0002-4258-3764
Case Report vs Cross-Sectional Study: A Simple Explanation
A case report is the description of the clinical story of a single patient. A cross-sectional study involves a group of participants on which data is collected at a single point in time to investigate the relationship between a certain exposure and an outcome.
Here’s a table that summarizes the relationship between a case report and a cross-sectional study:
Further reading
- Case Report: A Beginner’s Guide with Examples
- Case Report vs Case-Control Study
- Cohort vs Cross-Sectional Study
- How to Identify Different Types of Cohort Studies?
- Matched Pairs Design
- Randomized Block Design
We've updated our privacy policy. Click here to review the details. Tap here to review the details.
Activate your 30 day free trial to unlock unlimited reading.
Observational descriptive study: case report, case series & ecological study

You are reading a preview.
Activate your 30 day free trial to continue reading.

Check these out next

This presentation provides overview on observational study designs
Recommended

More Related Content
Slideshows for you (20).

Similar to Observational descriptive study: case report, case series & ecological study (20)

More from Prabesh Ghimire (20)

Recently uploaded (20)

- 1. RESEARCH DESIGN Prabesh Ghimire
- 2. Types of Research Design Prabesh Ghimire, MPH 2
- 3. Types of Research Design Non-Intervention Observational Design Intervention Design Population Based Individual Based Descriptive (Health Survey) Ecological Study Descriptive Case Report/ Case Series Analytical Cross-sectional or Prevalence Study Case- Control Study Cohort Study Randomized Control Trial or Clinical Trial Non-randomized Quasi Experimental Field Trial Cross-over Design Parallel Design Research Designs Prabesh Ghimire, MPH 3
- 4. Types of Research Design • Observational/ Non-Intervention Design • Observe both exposures and outcomes • Intervention Design • Assign exposures • Observe outcomes Prabesh Ghimire, MPH 4
- 5. Hierarchy of Scientific Evidence Prabesh Ghimire, MPH 5
- 6. Observational Design • Allows nature to take its course • The investigator observes/ measures but does not intervene. • Types • Descriptive (Case report, case series, ecological, cross-sectional) • Analytical (Cross-sectional, case-control, cohort) Prabesh Ghimire, MPH 6
- 7. Case Report Prabesh Ghimire, MPH 7
- 8. Case Report • A case report is a detailed description of disease occurrence, diagnosis, treatment, response to treatment, and follow-up after treatment of an individual person. • Case reports usually describe an unusual or novel occurrence and as such, remain one of the cornerstones of public health progress and provide many new ideas in public health. • Unusual features of the case may suggest a new hypothesis about the causes or mechanisms of disease. Prabesh Ghimire, MPH 8
- 9. Case Report Case reports often describe: • Unique cases that cannot be explained by known diseases or syndromes • Cases that show an important variation of a disease or condition • Cases that show unexpected events that may yield new or useful information • Cases in which one patient has two or more unexpected diseases or disorders Prabesh Ghimire, MPH 9
- 10. Reasons for preparing case report Case reports are prepared to keep record of • an unexpected association between diseases or symptoms; • an unexpected event in the course observing or treating a patient; • findings that shed new light on the possible pathogenesis of a disease or an adverse effect; • unique or rare features of a disease; • unique therapeutic approaches; variation of anatomical structures. Prabesh Ghimire, MPH 10
- 11. Case Report • Case reports are considered the lowest level of evidence, but they are also the first line of evidence, because they are where new issues and ideas emerge. • If multiple case reports show something similar, the next step might be a case-control study to determine if there is a relationship between the relevant variables. Prabesh Ghimire, MPH 11
- 12. Case Report Case report should provide the following case details • Case description (socio-demographic information) • Case history • Physical examination results • Results of pathological tests and other investigations • Treatment plan • Expected outcome of the treatment plan • Actual outcome Prabesh Ghimire, MPH 12
- 13. Case Report Strengths • Can help in the identification of new trends or diseases • Can help detect new drug side effects and potential uses (adverse or beneficial) • Educational -a way of sharing lessons learned • Identifies rare manifestations of a disease (for example in covid- 19) Prabesh Ghimire, MPH 13
- 14. Case Report Limitations • Cases may not be generalizable • Not based on systematic studies • Causes or associations may have other explanations • Can be seen as emphasizing the bizarre or focusing on misleading elements Prabesh Ghimire, MPH 14
- 15. Case Series Prabesh Ghimire, MPH 15
- 16. Case Series • A case series is a descriptive study that follows a group of patients with common characteristics used to describe some clinical, pathophysiological or operational aspects of a disease, treatment or diagnostic procedures. • The primary purpose of a case series is generation of hypotheses that subsequently can be tested in studies of greater methodological rigor. Prabesh Ghimire, MPH 16
- 17. Case Series • It is most useful for describing the potential effectiveness of new interventions, for describing the effectiveness of interventions on unusual diagnoses, and for describing unusual responses (either good or bad) to interventions. • Case series can be conducted retrospectively or prospectively. Prabesh Ghimire, MPH 17
- 18. When to consider a Case Series • When a more cautious description of interventions in several settings in required. • To report on novel diagnostic or therapeutic strategies, particularly when the option of waiting for comparative evidence is considered unacceptable. Prabesh Ghimire, MPH 18
- 19. Importance of Case Series Clinical case-‐ series are of value in public health field for: • Studying predictive symptoms, signs, and tests. • Creating case definitions • Clinical education, audit, and research • Health services research • Establishing safety profiles Prabesh Ghimire, MPH 19
- 20. Types of Case Series On the basis of recruitment Consecutive case series: • Includes all eligible patients identified by the researchers during the study period. • The patients are treated in the order in which they are identified. • Consecutiveness increases the quality of the case series. Non-consecutive case series: • Includes some, but not all, of the eligible patients identified by the researchers during the study period. Prabesh Ghimire, MPH 20
- 21. Types of Case Series On the basis of sampling Exposure-based sampling • Include all patients treated and have specific outcomes or adverse events. • Sampling is based on both a specific outcome and presence of a specific exposure. Outcome-based sampling • Includes patients with the specific outcome regardless of exposure. • Thus neither absolute risk nor relative risk can be calculated. • Selection is based only on a specific outcome, and data are collected on previous exposures. Prabesh Ghimire, MPH 21
- 22. Designing a good case series Research Question • The study question should list its study population, the intervention, and the primary outcome. Setting • Select a suitable observation period and identify cases with events in this period. • It may be tempting to include patients seen over a large period of time to increase sample size. • However, the use of a short inclusion period minimizes known and unknown changes over time in co-interventions, prognosis, and even in the intervention under study Prabesh Ghimire, MPH 22
- 23. Designing a good case series Number of Cases • The general number of cases reported in a case series range from 20 to 50. • But may vary from as few as 2 or 3 to as many as more than 100 or even thousands. Data collection • Reports of case series usually contain detailed information about the individual patients. • This includes demographic information (for example, age, gender, ethnic origin) and information on diagnosis, treatment, response to treatment, and follow-up after treatment Prabesh Ghimire, MPH 23
- 24. Designing a good case series What • The diagnosis or case definition should be clear and applied equally to all individuals in the series. • The case definition should mention the inclusion and exclusion criteria, which should be based on widely used validated definitions. • When: The date when the disease or death occurred (time). • Where: The place where the person lived, worked etc (place). Prabesh Ghimire, MPH 24
- 25. Designing a good case series Who • The characteristics of the population (person). • Noting the socio-demographic characteristics of a series of cases, as well as the temporal and spatial distributions can sometimes provide a clue to risk factors and hence help generate a hypothesis. • This can be tested subsequently with more elaborate analytic studies. Prabesh Ghimire, MPH 25
- 26. Designing a good case series • A detailed description of the intervention and the co-intervention should be stated. This will ensure repeatability of the study by other investigators. • It is very important to thoroughly describe co-interventions (for example, physical therapy) • The most important outcomes in care are those that measure patient satisfaction, relief of symptoms, and a feeling of well- being. • An example is the Short Form-36 questionnaire, which not only measures physical function but also mental well-being. Prabesh Ghimire, MPH 26
- 27. Designing a good case series Methods of data collection • The method of data acquisition (telephone interview, clinical measurement, or chart review) should be addressed in the study report Analysis • Only descriptive statistics should be used. • Findings can be presented as proportions (%) of the study populations with the outcome, confidence intervals; means, standard deviations for continuous variables • No comparative tests yielding p values should be done. Prabesh Ghimire, MPH 27
- 28. Designing a good case series Reporting • A statement of the external validity of the obtained data should be given. This includes patient characteristics and completeness of follow-up. • The follow-up rates and reasons for loss to follow-up should be stated. • No absolute conclusions on the studied treatment should be stated. As mentioned before, the lack of a comparison group prohibits any hypothesis from being tested. • Valid conclusion: “Patients treated by treatment X showed good outcome Y after Z months of follow-up.” • Stating that “treatment X is better than treatment Y” or even that “treatment X is effective” would be invalid. Prabesh Ghimire, MPH 28
- 29. Strengths and Limitations Strengths • High external validity: the study results are closer to those obtained in routine clinical practice and may, therefore, be considered more relevant. • It could be useful when a randomized controlled trial is not appropriate or possible. • No interference in the treatment decision process • Wide range of patients can be studied • In-expensive • Conduction of study take little time • Useful for hypothesis generation • Informative for very rare disease with few established risk factors. Prabesh Ghimire, MPH 29
- 30. Strengths and Limitations Limitations • Lack of a control (or comparison) group • Lack of a denominator to calculate rates of disease. • Causal inferences cannot be made • Data collection often incomplete • Susceptible to bias (selection bias, measurement bias) Prabesh Ghimire, MPH 30
- 31. For further reading • https://asploro.com/what-is-case- series/#:~:text=Non%2DConsecutive%20Case%20Series%3A%20%5B,quality%20of%20 the%20case%20series. • Mathes, T., & Pieper, D. (2017). Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload. BMC medical research methodology, 17(1), 107. https://doi.org/10.1186/s12874-017-0391-8 • Abu-Zidan, F. M., Abbas, A. K., & Hefny, A. F. (2012). Clinical "case series": a concept analysis. African health sciences, 12(4), 557–562. • https://www.researchgate.net/publication/327449197_What_is_case_series Prabesh Ghimire, MPH 31
- 32. Ecological Study Design Prabesh Ghimire, MPH 32
- 33. Ecological Study • Observational study in which data are analyzed at the population or community level rather than individual level. • Disease rates and exposures are measured in each of a series of populations and their relations is examined. • Often the information about disease and exposure is abstracted from published statistics and therefore does not require expensive or time consuming data collection. • In ecological studies health outcomes are aggregates of individual health data. E.g. prevalence, incidence, rate of diseases. Prabesh Ghimire, MPH 33
- 34. Years of education Teenage pregnancy (Yes/No) Prevalence/ Rate of Teenage Pregnancy Association Avg. no. of years of education Prabesh Ghimire, MPH 34
- 35. Purpose of ecological study • To monitor population health so that public health strategies may be developed and directed. • To make large scale comparisons, e.g. comparisons between countries; • To study the relationship between population-level exposure to risk factors and diseases or in-order to look at the contextual effect of risk factors on the population • When disease under investigation is rare, requiring aggregation of data for any analysis to be carried out. • When measurement at individual level are not available. E.g. confidentiality might require that individuals are anonymized by aggregation of data to small area level. Prabesh Ghimire, MPH 35
- 36. Types of Ecological Study Geographical • One common approach is to look for geographical correlations between disease incidence or mortality and the prevalence of risk factors. • For example, mortality from coronary heart disease in local authority areas of England and Wales has been correlated with neonatal mortality in the same places 70 and more years earlier. • This observation generated the hypothesis that coronary heart disease may result from the impaired development of blood vessels and other tissues in fetal life and infancy. Prabesh Ghimire, MPH 36
- 37. Types of Ecological Study Longitudinal/Time trends • Many diseases show remarkable fluctuations in incidence over time. • Epidemics of chronic disorders such as lung cancer and coronary heart disease evolve over decades. • If time or secular trends in disease incidence correlate with changes in a community’s environment or way of life then the trends may provide important clues to aetiology. • Example: In Britain, successive rises and falls in mortality from cervical cancer have been related to varying levels of sexual promiscuity, as evidenced by notification rates for gonorrhoea. Prabesh Ghimire, MPH 37
- 38. Types of Ecological Study Migrant studies • In migrant studies, the disease rate among persons who have migrated from one location to another is compared with the disease rate in persons who did not migrate. • Second generation Japanese migrants to the USA have substantially lower rates of stomach cancer than Japanese people in Japan, indicating that the high incidence of the disease in Japan is environmental in origin. Prabesh Ghimire, MPH 38
- 39. Ecological Study • Advantage • Inexpensive and easy to carry-out using routinely collected data • Useful for performing international comparisons and studying group- level effects (correlation between rates from CVD and cigarette sales per capita) • Disadvantage • Prone to bias and confounding • Caution is needed when applying grouped results to the individual level Prabesh Ghimire, MPH 39
- 40. Ecological Study Examples • Assessment of various dietary factors and cancer mortality and incidence by country. • Incidence rates for 27 cancers in 23 countries and mortality rates for 14 cancers in 32 countries have been correlated with a wide range of dietary and other variables. • Source: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910150411 Prabesh Ghimire, MPH 40
- 41. Ecological Fallacy • Type of confounding specific to ecological studies. • Occurs when relationships which exists for groups are assumed to also be true for groups. • It is an error in the interpretation of the results of an ecological study, where conclusions are inappropriately inferred about individuals from the results of aggregate data. • The fallacy assumes that individual members of a group all have the average characteristics of the group as whole, when in fact any association observed between variables at the group level does not necessarily mean that the same association exists for any given individual selected from the group. Prabesh Ghimire, MPH 41
- 42. Ecological Fallacy • For example, it has been observed that the number of televisions per capita is negatively associated with the rate of deaths from heart disease. • However, it would be an ecological fallacy to infer that people who don’t own televisions die from heart disease. • Indeed, in this scenario there are other potentially causative factors that could be common to both, such as reduced physical activity or a poorer diet associated with less affluent societies. Prabesh Ghimire, MPH 42
- 43. Ecological Fallacy • In ecologic studies, only information on aggregate measures, such as the average exposure in City A and the death rate in City A can be known. • At the individual level, however, we can, for example, determine the proportion of people who died within each of the categories of exposure (low or high). Prabesh Ghimire, MPH 43
- 44. Example of ecological fallacy • Suppose indoor air pollution is higher in Bajura than in Achham, but mortality from COPD is lower in Bajura than in Achham. • It would be fallacious to conclude that indoor air pollution protects against COPD deaths. • It is possible that persons dying of COPD in Achham may have moved from cities with high indoor air pollution or that another risk factor for COPD – such as smoking – is more prevalent in Achham than Bajura. • We do not know the cumulative exposures of cases and non-cases in either district. • The heterogeneity of lifetime air pollution exposure among individuals in each district makes the average exposure unrepresentative of the distribution of exposure among individuals in the population. Prabesh Ghimire, MPH 44
- 45. Criteria for ecological fallacy Ecological fallacy exists if it meets all of these three criteria • Results must be obtained with ecological data • Data must be inferred to individuals. • Results obtained with individual data are contradictory Prabesh Ghimire, MPH 45
- 46. Reasons for ecological fallacy • It is not possible to link exposure with disease in individuals - those with disease may not be the same people in the population who are exposed. • The data used may have originally been collected for other purposes. • Inability to control for confounding. Prabesh Ghimire, MPH 46
- 47. THANK YOU Prabesh Ghimire, MPH 47
Share Clipboard
Public clipboards featuring this slide, select another clipboard.
Looks like you’ve clipped this slide to already.
You just clipped your first slide!
Create a clipboard
Get slideshare without ads, special offer to slideshare readers, just for you: free 60-day trial to the world’s largest digital library..
The SlideShare family just got bigger. Enjoy access to millions of ebooks, audiobooks, magazines, and more from Scribd.

You have now unlocked unlimited access to 20M+ documents!
Unlimited Reading
Learn faster and smarter from top experts
Unlimited Downloading
Download to take your learnings offline and on the go
Instant access to millions of ebooks, audiobooks, magazines, podcasts and more.
Read and listen offline with any device.
Free access to premium services like Tuneln, Mubi and more.
Help us keep SlideShare free
It appears that you have an ad-blocker running. By whitelisting SlideShare on your ad-blocker, you are supporting our community of content creators.
We've updated our privacy policy.
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
6.5 Observational Research
Learning objectives.
- List the various types of observational research methods and distinguish between each
- Describe the strengths and weakness of each observational research method.
What Is Observational Research?
The term observational research is used to refer to several different types of non-experimental studies in which behavior is systematically observed and recorded. The goal of observational research is to describe a variable or set of variables. More generally, the goal is to obtain a snapshot of specific characteristics of an individual, group, or setting. As described previously, observational research is non-experimental because nothing is manipulated or controlled, and as such we cannot arrive at causal conclusions using this approach. The data that are collected in observational research studies are often qualitative in nature but they may also be quantitative or both (mixed-methods). There are several different types of observational research designs that will be described below.
Naturalistic Observation
Naturalistic observation is an observational method that involves observing people’s behavior in the environment in which it typically occurs. Thus naturalistic observation is a type of field research (as opposed to a type of laboratory research). Jane Goodall’s famous research on chimpanzees is a classic example of naturalistic observation. Dr. Goodall spent three decades observing chimpanzees in their natural environment in East Africa. She examined such things as chimpanzee’s social structure, mating patterns, gender roles, family structure, and care of offspring by observing them in the wild. However, naturalistic observation could more simply involve observing shoppers in a grocery store, children on a school playground, or psychiatric inpatients in their wards. Researchers engaged in naturalistic observation usually make their observations as unobtrusively as possible so that participants are not aware that they are being studied. Such an approach is called disguised naturalistic observation. Ethically, this method is considered to be acceptable if the participants remain anonymous and the behavior occurs in a public setting where people would not normally have an expectation of privacy. Grocery shoppers putting items into their shopping carts, for example, are engaged in public behavior that is easily observable by store employees and other shoppers. For this reason, most researchers would consider it ethically acceptable to observe them for a study. On the other hand, one of the arguments against the ethicality of the naturalistic observation of “bathroom behavior” discussed earlier in the book is that people have a reasonable expectation of privacy even in a public restroom and that this expectation was violated.
In cases where it is not ethical or practical to conduct disguised naturalistic observation, researchers can conduct undisguised naturalistic observation where the participants are made aware of the researcher presence and monitoring of their behavior. However, one concern with undisguised naturalistic observation is reactivity. Reactivity refers to when a measure changes participants’ behavior. In the case of undisguised naturalistic observation, the concern with reactivity is that when people know they are being observed and studied, they may act differently than they normally would. For instance, you may act much differently in a bar if you know that someone is observing you and recording your behaviors and this would invalidate the study. So disguised observation is less reactive and therefore can have higher validity because people are not aware that their behaviors are being observed and recorded. However, we now know that people often become used to being observed and with time they begin to behave naturally in the researcher’s presence. In other words, over time people habituate to being observed. Think about reality shows like Big Brother or Survivor where people are constantly being observed and recorded. While they may be on their best behavior at first, in a fairly short amount of time they are, flirting, having sex, wearing next to nothing, screaming at each other, and at times acting like complete fools in front of the entire nation.
Participant Observation
Another approach to data collection in observational research is participant observation. In participant observation , researchers become active participants in the group or situation they are studying. Participant observation is very similar to naturalistic observation in that it involves observing people’s behavior in the environment in which it typically occurs. As with naturalistic observation, the data that is collected can include interviews (usually unstructured), notes based on their observations and interactions, documents, photographs, and other artifacts. The only difference between naturalistic observation and participant observation is that researchers engaged in participant observation become active members of the group or situations they are studying. The basic rationale for participant observation is that there may be important information that is only accessible to, or can be interpreted only by, someone who is an active participant in the group or situation. Like naturalistic observation, participant observation can be either disguised or undisguised. In disguised participant observation, the researchers pretend to be members of the social group they are observing and conceal their true identity as researchers. In contrast with undisguised participant observation, the researchers become a part of the group they are studying and they disclose their true identity as researchers to the group under investigation. Once again there are important ethical issues to consider with disguised participant observation. First no informed consent can be obtained and second passive deception is being used. The researcher is passively deceiving the participants by intentionally withholding information about their motivations for being a part of the social group they are studying. But sometimes disguised participation is the only way to access a protective group (like a cult). Further, disguised participant observation is less prone to reactivity than undisguised participant observation.
Rosenhan’s study (1973) [1] of the experience of people in a psychiatric ward would be considered disguised participant observation because Rosenhan and his pseudopatients were admitted into psychiatric hospitals on the pretense of being patients so that they could observe the way that psychiatric patients are treated by staff. The staff and other patients were unaware of their true identities as researchers.
Another example of participant observation comes from a study by sociologist Amy Wilkins (published in Social Psychology Quarterly ) on a university-based religious organization that emphasized how happy its members were (Wilkins, 2008) [2] . Wilkins spent 12 months attending and participating in the group’s meetings and social events, and she interviewed several group members. In her study, Wilkins identified several ways in which the group “enforced” happiness—for example, by continually talking about happiness, discouraging the expression of negative emotions, and using happiness as a way to distinguish themselves from other groups.
One of the primary benefits of participant observation is that the researcher is in a much better position to understand the viewpoint and experiences of the people they are studying when they are apart of the social group. The primary limitation with this approach is that the mere presence of the observer could affect the behavior of the people being observed. While this is also a concern with naturalistic observation when researchers because active members of the social group they are studying, additional concerns arise that they may change the social dynamics and/or influence the behavior of the people they are studying. Similarly, if the researcher acts as a participant observer there can be concerns with biases resulting from developing relationships with the participants. Concretely, the researcher may become less objective resulting in more experimenter bias.
Structured Observation
Another observational method is structured observation. Here the investigator makes careful observations of one or more specific behaviors in a particular setting that is more structured than the settings used in naturalistic and participant observation. Often the setting in which the observations are made is not the natural setting, rather the researcher may observe people in the laboratory environment. Alternatively, the researcher may observe people in a natural setting (like a classroom setting) that they have structured some way, for instance by introducing some specific task participants are to engage in or by introducing a specific social situation or manipulation. Structured observation is very similar to naturalistic observation and participant observation in that in all cases researchers are observing naturally occurring behavior, however, the emphasis in structured observation is on gathering quantitative rather than qualitative data. Researchers using this approach are interested in a limited set of behaviors. This allows them to quantify the behaviors they are observing. In other words, structured observation is less global than naturalistic and participant observation because the researcher engaged in structured observations is interested in a small number of specific behaviors. Therefore, rather than recording everything that happens, the researcher only focuses on very specific behaviors of interest.
Structured observation is very similar to naturalistic observation and participant observation in that in all cases researchers are observing naturally occurring behavior, however, the emphasis in structured observation is on gathering quantitative rather than qualitative data. Researchers using this approach are interested in a limited set of behaviors. This allows them to quantify the behaviors they are observing. In other words, structured observation is less global than naturalistic and participant observation because the researcher engaged in structured observations is interested in a small number of specific behaviors. Therefore, rather than recording everything that happens, the researcher only focuses on very specific behaviors of interest.
Researchers Robert Levine and Ara Norenzayan used structured observation to study differences in the “pace of life” across countries (Levine & Norenzayan, 1999) [3] . One of their measures involved observing pedestrians in a large city to see how long it took them to walk 60 feet. They found that people in some countries walked reliably faster than people in other countries. For example, people in Canada and Sweden covered 60 feet in just under 13 seconds on average, while people in Brazil and Romania took close to 17 seconds. When structured observation takes place in the complex and even chaotic “real world,” the questions of when, where, and under what conditions the observations will be made, and who exactly will be observed are important to consider. Levine and Norenzayan described their sampling process as follows:
“Male and female walking speed over a distance of 60 feet was measured in at least two locations in main downtown areas in each city. Measurements were taken during main business hours on clear summer days. All locations were flat, unobstructed, had broad sidewalks, and were sufficiently uncrowded to allow pedestrians to move at potentially maximum speeds. To control for the effects of socializing, only pedestrians walking alone were used. Children, individuals with obvious physical handicaps, and window-shoppers were not timed. Thirty-five men and 35 women were timed in most cities.” (p. 186). Precise specification of the sampling process in this way makes data collection manageable for the observers, and it also provides some control over important extraneous variables. For example, by making their observations on clear summer days in all countries, Levine and Norenzayan controlled for effects of the weather on people’s walking speeds. In Levine and Norenzayan’s study, measurement was relatively straightforward. They simply measured out a 60-foot distance along a city sidewalk and then used a stopwatch to time participants as they walked over that distance.
As another example, researchers Robert Kraut and Robert Johnston wanted to study bowlers’ reactions to their shots, both when they were facing the pins and then when they turned toward their companions (Kraut & Johnston, 1979) [4] . But what “reactions” should they observe? Based on previous research and their own pilot testing, Kraut and Johnston created a list of reactions that included “closed smile,” “open smile,” “laugh,” “neutral face,” “look down,” “look away,” and “face cover” (covering one’s face with one’s hands). The observers committed this list to memory and then practiced by coding the reactions of bowlers who had been videotaped. During the actual study, the observers spoke into an audio recorder, describing the reactions they observed. Among the most interesting results of this study was that bowlers rarely smiled while they still faced the pins. They were much more likely to smile after they turned toward their companions, suggesting that smiling is not purely an expression of happiness but also a form of social communication.
When the observations require a judgment on the part of the observers—as in Kraut and Johnston’s study—this process is often described as coding . Coding generally requires clearly defining a set of target behaviors. The observers then categorize participants individually in terms of which behavior they have engaged in and the number of times they engaged in each behavior. The observers might even record the duration of each behavior. The target behaviors must be defined in such a way that different observers code them in the same way. This difficulty with coding is the issue of interrater reliability, as mentioned in Chapter 4. Researchers are expected to demonstrate the interrater reliability of their coding procedure by having multiple raters code the same behaviors independently and then showing that the different observers are in close agreement. Kraut and Johnston, for example, video recorded a subset of their participants’ reactions and had two observers independently code them. The two observers showed that they agreed on the reactions that were exhibited 97% of the time, indicating good interrater reliability.
One of the primary benefits of structured observation is that it is far more efficient than naturalistic and participant observation. Since the researchers are focused on specific behaviors this reduces time and expense. Also, often times the environment is structured to encourage the behaviors of interested which again means that researchers do not have to invest as much time in waiting for the behaviors of interest to naturally occur. Finally, researchers using this approach can clearly exert greater control over the environment. However, when researchers exert more control over the environment it may make the environment less natural which decreases external validity. It is less clear for instance whether structured observations made in a laboratory environment will generalize to a real world environment. Furthermore, since researchers engaged in structured observation are often not disguised there may be more concerns with reactivity.
Case Studies
A case study is an in-depth examination of an individual. Sometimes case studies are also completed on social units (e.g., a cult) and events (e.g., a natural disaster). Most commonly in psychology, however, case studies provide a detailed description and analysis of an individual. Often the individual has a rare or unusual condition or disorder or has damage to a specific region of the brain.
Like many observational research methods, case studies tend to be more qualitative in nature. Case study methods involve an in-depth, and often a longitudinal examination of an individual. Depending on the focus of the case study, individuals may or may not be observed in their natural setting. If the natural setting is not what is of interest, then the individual may be brought into a therapist’s office or a researcher’s lab for study. Also, the bulk of the case study report will focus on in-depth descriptions of the person rather than on statistical analyses. With that said some quantitative data may also be included in the write-up of a case study. For instance, an individuals’ depression score may be compared to normative scores or their score before and after treatment may be compared. As with other qualitative methods, a variety of different methods and tools can be used to collect information on the case. For instance, interviews, naturalistic observation, structured observation, psychological testing (e.g., IQ test), and/or physiological measurements (e.g., brain scans) may be used to collect information on the individual.
HM is one of the most notorious case studies in psychology. HM suffered from intractable and very severe epilepsy. A surgeon localized HM’s epilepsy to his medial temporal lobe and in 1953 he removed large sections of his hippocampus in an attempt to stop the seizures. The treatment was a success, in that it resolved his epilepsy and his IQ and personality were unaffected. However, the doctors soon realized that HM exhibited a strange form of amnesia, called anterograde amnesia. HM was able to carry out a conversation and he could remember short strings of letters, digits, and words. Basically, his short term memory was preserved. However, HM could not commit new events to memory. He lost the ability to transfer information from his short-term memory to his long term memory, something memory researchers call consolidation. So while he could carry on a conversation with someone, he would completely forget the conversation after it ended. This was an extremely important case study for memory researchers because it suggested that there’s a dissociation between short-term memory and long-term memory, it suggested that these were two different abilities sub-served by different areas of the brain. It also suggested that the temporal lobes are particularly important for consolidating new information (i.e., for transferring information from short-term memory to long-term memory).
www.youtube.com/watch?v=KkaXNvzE4pk
The history of psychology is filled with influential cases studies, such as Sigmund Freud’s description of “Anna O.” (see Note 6.1 “The Case of “Anna O.””) and John Watson and Rosalie Rayner’s description of Little Albert (Watson & Rayner, 1920) [5] , who learned to fear a white rat—along with other furry objects—when the researchers made a loud noise while he was playing with the rat.
The Case of “Anna O.”
Sigmund Freud used the case of a young woman he called “Anna O.” to illustrate many principles of his theory of psychoanalysis (Freud, 1961) [6] . (Her real name was Bertha Pappenheim, and she was an early feminist who went on to make important contributions to the field of social work.) Anna had come to Freud’s colleague Josef Breuer around 1880 with a variety of odd physical and psychological symptoms. One of them was that for several weeks she was unable to drink any fluids. According to Freud,
She would take up the glass of water that she longed for, but as soon as it touched her lips she would push it away like someone suffering from hydrophobia.…She lived only on fruit, such as melons, etc., so as to lessen her tormenting thirst. (p. 9)
But according to Freud, a breakthrough came one day while Anna was under hypnosis.
[S]he grumbled about her English “lady-companion,” whom she did not care for, and went on to describe, with every sign of disgust, how she had once gone into this lady’s room and how her little dog—horrid creature!—had drunk out of a glass there. The patient had said nothing, as she had wanted to be polite. After giving further energetic expression to the anger she had held back, she asked for something to drink, drank a large quantity of water without any difficulty, and awoke from her hypnosis with the glass at her lips; and thereupon the disturbance vanished, never to return. (p.9)
Freud’s interpretation was that Anna had repressed the memory of this incident along with the emotion that it triggered and that this was what had caused her inability to drink. Furthermore, her recollection of the incident, along with her expression of the emotion she had repressed, caused the symptom to go away.
As an illustration of Freud’s theory, the case study of Anna O. is quite effective. As evidence for the theory, however, it is essentially worthless. The description provides no way of knowing whether Anna had really repressed the memory of the dog drinking from the glass, whether this repression had caused her inability to drink, or whether recalling this “trauma” relieved the symptom. It is also unclear from this case study how typical or atypical Anna’s experience was.

Figure 10.1 Anna O. “Anna O.” was the subject of a famous case study used by Freud to illustrate the principles of psychoanalysis. Source: http://en.wikipedia.org/wiki/File:Pappenheim_1882.jpg
Case studies are useful because they provide a level of detailed analysis not found in many other research methods and greater insights may be gained from this more detailed analysis. As a result of the case study, the researcher may gain a sharpened understanding of what might become important to look at more extensively in future more controlled research. Case studies are also often the only way to study rare conditions because it may be impossible to find a large enough sample to individuals with the condition to use quantitative methods. Although at first glance a case study of a rare individual might seem to tell us little about ourselves, they often do provide insights into normal behavior. The case of HM provided important insights into the role of the hippocampus in memory consolidation. However, it is important to note that while case studies can provide insights into certain areas and variables to study, and can be useful in helping develop theories, they should never be used as evidence for theories. In other words, case studies can be used as inspiration to formulate theories and hypotheses, but those hypotheses and theories then need to be formally tested using more rigorous quantitative methods.
The reason case studies shouldn’t be used to provide support for theories is that they suffer from problems with internal and external validity. Case studies lack the proper controls that true experiments contain. As such they suffer from problems with internal validity, so they cannot be used to determine causation. For instance, during HM’s surgery, the surgeon may have accidentally lesioned another area of HM’s brain (indeed questioning into the possibility of a separate brain lesion began after HM’s death and dissection of his brain) and that lesion may have contributed to his inability to consolidate new information. The fact is, with case studies we cannot rule out these sorts of alternative explanations. So as with all observational methods case studies do not permit determination of causation. In addition, because case studies are often of a single individual, and typically a very abnormal individual, researchers cannot generalize their conclusions to other individuals. Recall that with most research designs there is a trade-off between internal and external validity, with case studies, however, there are problems with both internal validity and external validity. So there are limits both to the ability to determine causation and to generalize the results. A final limitation of case studies is that ample opportunity exists for the theoretical biases of the researcher to color or bias the case description. Indeed, there have been accusations that the woman who studied HM destroyed a lot of her data that were not published and she has been called into question for destroying contradictory data that didn’t support her theory about how memories are consolidated. There is a fascinating New York Times article that describes some of the controversies that ensued after HM’s death and analysis of his brain that can be found at: https://www.nytimes.com/2016/08/07/magazine/the-brain-that-couldnt-remember.html?_r=0
Archival Research
Another approach that is often considered observational research is the use of archival research which involves analyzing data that have already been collected for some other purpose. An example is a study by Brett Pelham and his colleagues on “implicit egotism”—the tendency for people to prefer people, places, and things that are similar to themselves (Pelham, Carvallo, & Jones, 2005) [7] . In one study, they examined Social Security records to show that women with the names Virginia, Georgia, Louise, and Florence were especially likely to have moved to the states of Virginia, Georgia, Louisiana, and Florida, respectively.
As with naturalistic observation, measurement can be more or less straightforward when working with archival data. For example, counting the number of people named Virginia who live in various states based on Social Security records is relatively straightforward. But consider a study by Christopher Peterson and his colleagues on the relationship between optimism and health using data that had been collected many years before for a study on adult development (Peterson, Seligman, & Vaillant, 1988) [8] . In the 1940s, healthy male college students had completed an open-ended questionnaire about difficult wartime experiences. In the late 1980s, Peterson and his colleagues reviewed the men’s questionnaire responses to obtain a measure of explanatory style—their habitual ways of explaining bad events that happen to them. More pessimistic people tend to blame themselves and expect long-term negative consequences that affect many aspects of their lives, while more optimistic people tend to blame outside forces and expect limited negative consequences. To obtain a measure of explanatory style for each participant, the researchers used a procedure in which all negative events mentioned in the questionnaire responses, and any causal explanations for them were identified and written on index cards. These were given to a separate group of raters who rated each explanation in terms of three separate dimensions of optimism-pessimism. These ratings were then averaged to produce an explanatory style score for each participant. The researchers then assessed the statistical relationship between the men’s explanatory style as undergraduate students and archival measures of their health at approximately 60 years of age. The primary result was that the more optimistic the men were as undergraduate students, the healthier they were as older men. Pearson’s r was +.25.
This method is an example of content analysis —a family of systematic approaches to measurement using complex archival data. Just as structured observation requires specifying the behaviors of interest and then noting them as they occur, content analysis requires specifying keywords, phrases, or ideas and then finding all occurrences of them in the data. These occurrences can then be counted, timed (e.g., the amount of time devoted to entertainment topics on the nightly news show), or analyzed in a variety of other ways.
Key Takeaways
- There are several different approaches to observational research including naturalistic observation, participant observation, structured observation, case studies, and archival research.
- Naturalistic observation is used to observe people in their natural setting, participant observation involves becoming an active member of the group being observed, structured observation involves coding a small number of behaviors in a quantitative manner, case studies are typically used to collect in-depth information on a single individual, and archival research involves analysing existing data.
- Describe one problem related to internal validity.
- Describe one problem related to external validity.
- Generate one hypothesis suggested by the case study that might be interesting to test in a systematic single-subject or group study.
- Rosenhan, D. L. (1973). On being sane in insane places. Science, 179 , 250–258. ↵
- Wilkins, A. (2008). “Happier than Non-Christians”: Collective emotions and symbolic boundaries among evangelical Christians. Social Psychology Quarterly, 71 , 281–301. ↵
- Levine, R. V., & Norenzayan, A. (1999). The pace of life in 31 countries. Journal of Cross-Cultural Psychology, 30 , 178–205. ↵
- Kraut, R. E., & Johnston, R. E. (1979). Social and emotional messages of smiling: An ethological approach. Journal of Personality and Social Psychology, 37 , 1539–1553. ↵
- Watson, J. B., & Rayner, R. (1920). Conditioned emotional reactions. Journal of Experimental Psychology, 3 , 1–14. ↵
- Freud, S. (1961). Five lectures on psycho-analysis . New York, NY: Norton. ↵
- Pelham, B. W., Carvallo, M., & Jones, J. T. (2005). Implicit egotism. Current Directions in Psychological Science, 14 , 106–110. ↵
- Peterson, C., Seligman, M. E. P., & Vaillant, G. E. (1988). Pessimistic explanatory style is a risk factor for physical illness: A thirty-five year longitudinal study. Journal of Personality and Social Psychology, 55 , 23–27. ↵

Share This Book
- Increase Font Size
- Chamberlain University Library
- Chamberlain Library Core
Finding Types of Research
- Observational Studies
On This Guide
- Evidence-Based Research
- Quantitative Studies
- Qualitative Studies
- Meta-Analysis
- Systematic Reviews
- Randomized Controlled Trials
What are Observational Studies?
Find observational articles, examples of observational studies.
- Literature Reviews
" Observational designs are nonexperimental, quantitative designs. In contrast to experimental designs in which the investigator manipulates the independent variable and observes its effect, the investigator conducting observational research observes both the independent and dependent variables. In observational studies, variation in the independent variable may be due to genetic endowment, self-selection, or occupational or environmental exposures" (Meininger, 2017).
There are three types of observational study designs:
- Case-control
- Cross-sectional
In a case-control study,
" participants are selected and categorized on the basis of the dependent variable (the outcome of interest). The purpose of the study is to test hypotheses about factors in the past (independent variables) that may explain the outcome" (Meininger, 2017).
With a cohort study,
"participants are measured or categorized on the basis of the independent variable and are monitored over time to observe occurrence of the dependent variable. In a cohort study, it is established at the outset that subjects have not already exhibited the outcomes of interest (dependent variable)" (Meininger, 2017).
And with a cross-sectional study,
"participants are observed only once, offering a 'snapshot' of the characteristics of interest at that particular moment" (Research Methods, 2008).
There are no specific limiters for these types of study designs. The best way to find these types of articles is to add a keyword of the study type to your search string. See examples below:
There are also a few things that you can do in specific databases that may increase the chance to find these types of studies. Below are two databases that will allow you to limit your search results to case reports, case studies, or observational studies only.
Medline Complete: Publication Type Filter
Case report, case study, observational study.
- Database - Medline Complete MEDLINE Complete provides authoritative medical information on general health & medicine, pharmacology, neurology, molecular biology, genetics and genomics, histology, microbiology and many other subject domains.
To find these types of observational studies in Medline, follow the steps below:
- Enter the database through the link above. This will take you directly to the advanced search page for this database. Enter your keyword(s) into the search boxes.
- Scroll down to the Limit Your Results section. This is where you can add filters to your search to tell the database that you only want articles that fit specific criteria.
- From the Publication Type scroll menu, select either Case Reports , Case Study , or Observational Study .
- After you have your results, make sure to read through the article abstracts to see which type of study design the researchers are using. There is no guarantee that the database will only generate these types of studies.
PubMed: Article Type Filter
Case reports and observational studies.
- Database - PubMed PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
To find these types of observational studies in PubMed, follow the steps below:
- Enter the database through the link above.
- Search your topic by entering your keywords into the search box and hitting search.
- Look to the left of the search results to see the list of available filters.
- Select Additional Filters at the bottom of the list to see more.
- This will generate a popup box where you can click on Article Type and choose either Case Reports or Observational Study .

Note! With any of these searches, you will need to limit to full text to get articles immediately available to you.
Case-Control
- Article - Association Between ABCB1 Gene Polymorphism and Renal Function in Patients with Hypertension: A Case-Control Study. Chen, X., Zhou, T., Yang, D., & Lu, J. (2017). Association between ABCB1 gene polymorphism and renal function in patients with hypertension: A case-control Study. Medical Science Monitor, 23, 3854–3860. https://doi.org/10.12659/MSM.902954
- Article - Association of Long-Term Exposure to Transportation Noise and Traffic-Related Air Pollution with the Incidence of Diabetes: A Prospective Cohort Study. Clark, C., Sbihi, H., Tamburic, L., Brauer, M., Frank, L.D., & Davies, H.W. (2017). Association of long-term exposure to transportation noise and traffic-related air pollution with the incidence of diabetes: A prospective cohort study. Environmental Health Perspectives, 125(8), 087025. https://doi.org/10.1289/EHP1279
- Article - A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study Whitlock, R.H., Hougen, I., Komenda, P., Rigatto, C., Clemens, K.K., & Tangri, N. (2020). A safety comparison of Metformin vs Sulfonylurea initiation in patients with type 2 diabetes and chronic kidney disease: A retrospective cohort study. Mayo Clinic Proceedings, 95(1), 90–100. https://doi.org/10.1016/j.mayocp.2019.07.017
Cross-Sectional
- Article - Preferences for models of peer support in the digital era: A cross-sectional survey of people with cancer. Boyes, A., Turon, H., Hall, A., Watson, R., Proietto, A., & Sanson‐Fisher, R. (2018). Preferences for models of peer support in the digital era: A cross‐sectional survey of people with cancer. Psycho-Oncology, 27 (9), 2148–2154. https://doi.org/10.1002/pon.4781
Meininger, J. C. (2017). Observational research designs. In J. Fitzpatrick (Ed.), Encyclopedia of nursing research (4th ed.). Springer Publishing Company.
Research methods and measurement and: Cross-sectional. (2008). In I. P. Albery, & M. Munafo, Key concepts in health psychology . Sage UK.
- Search Website
- Library Tech Support
- Services for Colleagues
Chamberlain College of Nursing is owned and operated by Chamberlain University LLC. In certain states, Chamberlain operates as Chamberlain College of Nursing pending state authorization for Chamberlain University.

Enhancing the QUAlity and Transparency Of health Research
- Courses & events
- Librarian Network
- Search for reporting guidelines
Use your browser's Back button to return to your search results
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies
Reporting guidelines for main study types, translations.
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section .
- About the Library
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library .
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Library index
- What is a reporting guideline?
- Browse reporting guidelines by specialty
- Reporting guidelines under development
- Translations of reporting guidelines
- EQUATOR Network reporting guideline manual
- Reporting guidelines for animal research
- Guidance on scientific writing
- Guidance developed by editorial groups
- Research funders’ guidance on reporting requirements
- Professional medical writing support
- Research ethics, publication ethics and good practice guidelines
- Links to other resources

An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
- Publications
- Account settings
- My Bibliography
- Collections
- Citation manager
Save citation to file
Email citation, add to collections.
- Create a new collection
- Add to an existing collection
Add to My Bibliography
Your saved search, create a file for external citation management software, your rss feed.
- Search in PubMed
- Search in NLM Catalog
- Add to Search
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports
Affiliations.
- 1 Jefe Del Servicio De Neurología/Neurology Service Head, Hospital Clínico Universitario, Santiago De Compostela, Spain.
- 2 Global Medical Affairs, Almirall S.A., Barcelona, Spain.
- PMID: 33749480
- DOI: 10.1080/14737175.2021.1904896
Introduction: : Nabiximols oromucosal spray,a cannabis-based medicine containing a balanced ratio of Δ-9-tetrahydrocannabinol and cannabidiol, is approved widely as an add-on therapy for symptomatic relief of spasticity in people with multiple sclerosis (MS). Most safety data for nabiximols derive from use in MS spasticity, with some data available from the analgesia area.
Areas covered: : This review compiles safety and tolerability data from all published observational studies, registry analyses, and case reports identified in systematic searches in which nabiximols oromucosal spray was investigated for spasticity (n = 20) and/or chronic non-cancer pain (n = 4). Aligning with the known safety profile of nabiximols as demonstrated in randomized controlled trials, common adverse events reported consistently across studies conducted under clinical practice conditions were dizziness, fatigue and somnolence. The serious adverse event (SAE) rate with nabiximols in MS spasticityobservational studies was 3.1% (137/4351). A total of 39 treatment-related SAEs were reported in 32 patients with spasticity, all of which (where specified) were resolved. No treatment-related SAEs were recorded in nabiximols pain studies.
Expert opinion: : Real-world experience with nabiximols oromucosal spray in treating spasticity and chronic pain indicates that, overall, it is well tolerated and has a good safety profile.
Keywords: Nabiximols; multiple sclerosis spasticity; neurological pain; observational studies; safety; sativex; tolerability.
Similar articles
- Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years" accumulated evidence from clinical trials. Prieto González JM, Vila Silván C. Prieto González JM, et al. Expert Rev Neurother. 2021 Jul;21(7):755-778. doi: 10.1080/14737175.2021.1935879. Epub 2021 Jul 21. Expert Rev Neurother. 2021. PMID: 34092180 Review.
- Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. Flachenecker P, Henze T, Zettl UK. Flachenecker P, et al. Eur Neurol. 2014;71(5-6):271-9. doi: 10.1159/000357427. Epub 2014 Feb 12. Eur Neurol. 2014. PMID: 24525548
- A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis. Carod-Artal FJ, Adjamian P, Vila Silván C, Bagul M, Gasperini C. Carod-Artal FJ, et al. Expert Rev Neurother. 2022 Jun;22(6):499-511. doi: 10.1080/14737175.2022.2075263. Epub 2022 Jun 1. Expert Rev Neurother. 2022. PMID: 35582858
- Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience. D'hooghe M, Willekens B, Delvaux V, D'haeseleer M, Guillaume D, Laureys G, Nagels G, Vanderdonckt P, Van Pesch V, Popescu V. D'hooghe M, et al. BMC Neurol. 2021 Jun 22;21(1):227. doi: 10.1186/s12883-021-02246-0. BMC Neurol. 2021. PMID: 34157999 Free PMC article.
- Review of Available Data for the Efficacy and Effectiveness of Nabiximols Oromucosal Spray (Sativex®) in Multiple Sclerosis Patients with Moderate to Severe Spasticity. Conte A, Vila Silván C. Conte A, et al. Neurodegener Dis. 2021;21(3-4):55-62. doi: 10.1159/000520560. Epub 2021 Nov 3. Neurodegener Dis. 2021. PMID: 34731865 Review.
Publication types
- Search in MeSH
Related information
- Cited in Books
- PubChem Compound (MeSH Keyword)
LinkOut - more resources
Full text sources.
- Taylor & Francis
Other Literature Sources
- scite Smart Citations
- MedlinePlus Health Information
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
- View all journals
- Explore content
- About the journal
- Publish with us
- Sign up for alerts
Similar articles being viewed by others
Slider with three articles shown per slide. Use the Previous and Next buttons to navigate the slides or the slide controller buttons at the end to navigate through each slide.

Short-term outcome after ischemic stroke and 24-h blood pressure variability: association and predictors
17 August 2020
Maria Kamieniarz-Mędrygał, Tomasz Łukomski & Radosław Kaźmierski

Increased blood pressure variability during the subacute phase of ischemic stroke is associated with poor functional outcomes at 3 months
21 January 2020
Hiroyuki Naito, Naohisa Hosomi, … Hirofumi Maruyama

Blood pressure fluctuation pattern and stroke outcomes in acute ischemic stroke
26 August 2019
Jie Xu, Ying Liu, … Yongjun Wang

Impact of in-hospital blood pressure variability on clinical outcomes in patients with symptomatic peripheral arterial disease
13 April 2021
Masahiro Suzuki, Yuichi Saito, … Yoshio Kobayashi

Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke: a post hoc analysis of the HeadPoST study
20 March 2019
Jatinder S. Minhas, Xia Wang, … on behalf of the HeadPoST Investigators

Time-variant associations of ambulatory pulse rate with short-term neurologic functional outcomes following acute ischemic stroke
11 October 2022
Bingbing Fan, Wei Lv, … Yongjun Wang

Association between blood pressure variability and the short-term outcome in patients with acute spontaneous subarachnoid hemorrhage
06 June 2019
Mengqi Yang, Xueying Pan, … Li Chen

Optimal blood pressure after reperfusion therapy in patients with acute ischemic stroke
05 April 2019
Kang-Ho Choi, Jae-Myung Kim, … Ki-Hyun Cho

Clinical impact of blood pressure on cardiovascular death in patients 80 years and older following acute myocardial infarction: a prospective cohort study
20 September 2022
Meng Zhang, Xiao-Ni Yan, … Jian-Jun Li
- Open Access
- Published: 03 March 2023
Significance of pulse pressure variability in predicting functional outcome in acute ischemic stroke: a retrospective, single-center, observational cohort study
- Maria Kamieniarz-Mędrygał 1 , 2 &
- Radosław Kaźmierski 3 , 4
Scientific Reports volume 13 , Article number: 3618 ( 2023 ) Cite this article
37 Accesses
Metrics details
- Hypertension
This study aimed to determine the association between pulse pressure variability (PPV) and short- and long-term outcomes of acute ischemic stroke (AIS) patients. We studied 203 tertiary stroke center patients with AIS. PPV during 72 h after admission was analyzed using different variability parameters including standard deviation (SD). Patients’ outcome was assessed after 30 and 90 days post-stroke with modified Rankin Scale. The association between PPV and outcome was investigated using logistic regression analysis with adjustment for potential confounders. The predictive significance of PPV parameters was determined using area under the curve (AUC) of receiver operating characteristics. In the unadjusted logistic regression analysis, all PPV indicators were independently associated with unfavorable outcome at 30 days (i.a. Odds ratio (OR) = 4.817, 95%CI 2.283–10.162 per 10 mmHg increase in SD, p = 0.000) and 90 days (i.a. OR = 4.248, 95%CI 2.044–8.831 per 10 mmHg increase in SD, p = 0.000). After adjustment for confounders, ORs for all PPV indicators remained statistically significant. On the basis of AUC values, all PPV parameters were found relevant outcome predictors (p < 0.01). In conclusion, elevated PPV during first 72 h after admission due to AIS is associated with unfavorable outcome at 30 and 90 days, independent of mean blood pressure levels.
Introduction
Acute hypertensive response occurs frequently in patients during ischemic stroke, but the pathophysiology of that phenomenon remains unknown 1 . Furthermore, it is not clear how to properly control blood pressure (BP) in hyperacute ischemic stroke 2 .Current guidelines suggest setting only the upper threshold of BP 3 . This threshold is different, depending whether the patient is undergoing reperfusion therapy such as intravenous thrombolysis (IVT) or mechanical thrombectomy (MT) or not undergoing such treatment 3 . Therapeutical intervention for BP control is only recommended if the upper BP threshold is exceeded, or in case some specific comorbidity (e.g. acute heart failure, acute coronary event, aorta dissection, preeclampsia) makes it necessary 4 . Current guidelines lack recommendations regarding the lower BP threshold as well as acceptable BP fluctuations in the acute period of stroke. In absence of randomized trials, recommendations are based on observational and retrospective studies and, as a consequence, their strength is weak 5 , 6 . Recent studies have not shown any benefit of aggressive BP reduction in hyperacute period 7 , 8 . By contrast, studies have proved the “U” shaped relationship between BP levels and worse patients outcome and death 9 , 10 .
Beside absolute BP levels, also blood pressure variability (BPV) turned out to be associated with unfavorable outcome 11 , 12 . BPV might be responsible for hypoperfusion and hyperperfusion of vulnerable ischemic penumbra, resulting in either enlargement of the ischemic area and cerebral oedema or hemorrhagic transformation. Currently, there is no unified research methodology for measuring BPV, precluding meta-analysis 13 , 14 . Most studies estimate BP fluctuations by systolic blood pressure (SBP) and mean arterial pressure (MAP) 15 . Diastolic blood pressure (DBP) is less frequently used, and only a few studies employed pulse pressure (PP). Independently of which BP component was the focus, studies up to date have typically used only a single BPV statistic parameter, usually standard deviation (SD), and only few publications took into account several different parameters 15 .
Elevated PP is associated with poor cardiovascular prognosis 16 . It was also demonstrated to be associated with post-stroke mortality and stroke recurrence 17 , 18 , 19 . Pulse pressure is a pulsatile and dynamic part of BP so it may better describe BP variability. However, only few studies addressed the role of PP variability (PPV) on stroke outcome and they only used single parameters 20 , 21 . Nevertheless they have found an association between high PPV and unfavorable clinical outcome in patients with AIS who underwent either IVT 20 as well as prognostic significance of PPV for AIS patients treated with MT 21 . The retrospective study in a group of patients not qualified to the thrombolytic treatment revealed also that PPV provided a prime predictor of bad outcome 22 . Hence, the aim of this study was to determine the relationship between PPV and stroke short- and long-term outcome using a variety of statistic parameters.
Study subjects and data collection
The study has a retrospective character and is based on an electronic database registered in our university stroke unit. The patients study group was collected in 2009–2011. Patients included in the study cohort were admitted to the hospital within 36 h from the onset of stroke symptoms. At admission, all patients were evaluated using National Institutes of Health Stroke Scale (NIHSS) and Glasgow Coma Scale 23 . At the same time, demographic data, comorbid conditions, history of previous cardiovascular diseases and baseline measures were collected. Further on, all patients underwent non-enhanced head computer tomography (CT) or magnetic resonance imaging (MRI) at admission and within 2–5 days after stroke onset. Patients were treated employing medication and care according to current national stroke guidelines 24 . From 227 patients collected in the database, 24 patients were excluded from further analysis because of insufficient data (lack of adequate number of BP measures in 14 patients, absence of follow-up visit in 6 patients) or death during the period of first 72 h post-stroke (4 patients). The flowchart in Fig. 1 shows the exclusions, which were mostly due to interruptions in successive four-hour-interval BP readings needed for the variability estimates. Patients’ written consent on participation in the study and collection of personal data was obtained during the time of hospitalization. Ethical approval for this study was issued by the Chairman of the Committee on Bioethics, Poznan University of Medical Sciences (decision from 15.04.2021). This study was completed in accordance with the Helsinki Declaration as revised in 2013.

Flowchart showing categories of patients excluded from the study.
BPV parameters
Blood pressure values were taken in the supine position in the non-paretic arm by a trained nurse using the Ultraview SL2600 monitoring system (Spacelabs Medical Inc., USA), which meets and exceeds the American National Standards Institute/Association for the Advancement of Medical Instrumentation (ANSI/AAMI) standard SP-10. In further analysis we used blood pressure measurements recorded in 4-h intervals from midnight after admission through next 72 h of hospitalization. PP was calculated as a difference between systolic and diastolic blood pressure (SBP—DBP). PPV was investigated using varied parameters, all employed in former studies 22 , 25 . The following formulae, where x i and \(\overline{x }\) stand for a single PP reading and the mean value of all readings, respectively, were exploited: standard deviation (SD, \(SD= \sqrt{1/(n-1){\sum_{i=1}^{n}({x}_{i}-\overline{x })}^{2}}\) ), coefficient of variation (CV, CV = 100xSD/ \(\overline{x }\) ), successive variation index (SV, \(SV=\sqrt{1/(n-1)\sum_{i=1}^{n-1}{({x}_{i+1}-{x}_{i})}^{2}}\) ), average real variability (ARV, \(ARV=1/(n-1){\sum }_{i=1}^{n-1}\left|{x}_{i+1}-{x}_{i}\right|\) ), difference maximum-minimum (DMM; difference between maximum and minimum PP value recorded) and maximal successive change (MSC; the highest difference between successive readings).
Functional outcome
The clinical outcome was assessed by trained neurologists at 30-days (short-term) and 90-days (long-term) follow-up, using the modified Rankin Scale (mRS). The functional assessment was preceded by an intraobserver reliability check comprising independent neurologists involved in prior studies 26 . Data on the degree of disability and independence in daily activities was gathered during a visit or by a telephone survey. It was obtained directly from the patients whenever possible, and otherwise from their caregivers. The functional outcome was dichotomized based on mRS score, unfavorable outcome was defined as mRS score ≥ 3 (dependance/death) while favorable outcome as mRS ≤ 2. This dichotomized division was used for the analyses employing the Mann–Whitney U test and in Model 1, 3 and 4 of logistic regression. In Model 2 of logistic regression, a ‘severity-adjusted’ outcome relying on admission NIHSS score, was employed 27 . In this case, the outcome was considered unfavorable when mRS score was 2–6 and NIHSS was ≤ 7, or mRS was 3–6 and NIHSS was between 8 and 14, or mRS was 4–6 and NIHSS was > 14. In other cases the outcome was considered favorable.
Statistical analysis
All data analysis was performed using Statistica 13.3 package (Tibco). All the items available in the database and relevant to the study were taken into account without prior sample size calculations. However, in our analysis the sample size is higher by more than one order of magnitude with respect to number of variables. Quantitative data were expressed as mean ± SD or median (interquartile range). Categorical variables were described as numbers (percentage). P values < 0.05 were considered statistically significant. To determine the relationship between PPV parameters and functional outcome in the groups considered, i.e. with/without thrombolytic treatment and the entire cohort, Spearman rank correlation test was used as a first approach. To assess the relationship, statistical significance of the correlation coefficients was invoked, considering moderate values of ρ S < 0.4. Similar moderate correlations of BPV indicators were reported before in stroke studies 28 . The statistical significance of differences between the groups of patients with/without thrombolytic treatment were evaluated with the Mann–Whitney U test. The association between PPV parameters and unfavorable outcome was examined with multivariable logistic regression analysis. The Odds ratios (OR) and 95% confidence intervals (CIs) were calculated per 10 mmHg increase in PPV parameter, as recommended in prior systematic review 15 . The predictive significance of PPV parameters was determined using receiver operating characteristics (ROC) curve analysis. The area under the curve (AUC) values, Youden’s Index and cut-off points were reported.
Informed consent
Written informed consent was obtained from all subjects before the study (at the time of original data collection).
203 patients were included in the study, out of which 48 (20%) were subject to thrombolytic treatment. None of the patients included underwent MT therapy. From the whole cohort, 82 patients achieved unfavorable outcome (mRS ≥ 3) at 30-days and 79 at 90-days after stroke. Patients were more likely to be dependent or dead at 30 days if they were female, were older or had higher admission NIHSS (left side of Table 1 ).
This also applied to the group with unfavorable outcome at 90 days (right side of Table 1 ). Additionally, there was no association between admission BP values and stroke short- and long term outcome (Table 1 ).
The relationship between PPV and 30 and 90 days outcome was analyzed in the thrombolysis and non-thrombolysis subgroups as well as in the whole cohort, using the Spearman rank correlation test (Table 2 ). All PPV indices were significantly associated with mRS score after 30- and 90-days (p < 0.05), with the exception of CV in the thrombolysis group. Interestingly, higher Spearman ρ values were observed in patients after recanalization therapy (Spearman ρ = 0.455 for MSC after 90 days outcome). According to the Mann–Whitney U test, there was no difference between mean PPV values in the groups with- or without thrombolytic treatment (p > 0.05, right side of Table 2 ). Based on this result, further analyses were performed in the whole cohort (n = 203). We observed that correlations between mean PP values and mRS scores were only relevant in the group with thrombolytic treatment (Table 2 ).
The next step of the study was the logistic regression analysis for short- and long-term outcome. The unadjusted model demonstrated that all PPV indices were associated with risk of unfavorable outcome at 30 and 90 days after AIS (Table 3 , Model 1). In Model 2, all PPV indices were adjusted for their mean values and the application of recombined tissue plasminogen activator (rtPA). The PPV indices were independently associated with poor outcome at 30 days (OR = 4.457, 95% CI 1.961–10.132 per 10 mmHg increase in SD, p = 0.000; OR = 1.473, 95% CI 1.190–1.823 for 10 mmHg increase in MSC, p = 0.000) and 90 days (OR = 3.666, 95% CI 1.648–8.156 per 10 mmHg increase in SD, p = 0.001; OR 1.439, 95% CI 1.167–1.774 per 10 mmHg increase in MSC, p = 0.001). Very similar odds ratios (OR) were found for PPV indices when the ‘adjusted outcome’ was employed, which took into consideration both mRS and baseline NIHSS scores, as mentioned in the methods (Model 3). Model 4 was an extension of Model 2 adjusting for age, gender and history of myocardial infarction. We conclude that ORs for all PPV indicators remain statistically significant, although their values steadily decrease, passing from Model 1 to Model 4. The exception are PP ARV and PP SD indices, for which the ORs are not statistically significant in Model 4 as far as the long-term outcome is concerned (right-bottom corner of Table 3 ).
The quality and usefulness of PPV indices as predictors of unfavorable outcome was also examined by the ROC curve analysis (Table 4 ).
On the basis of AUC values, all PPV parameters were found relevant outcome predictors (p < 0.01). The highest values of AUC amounts to 0.669 for PP DMM index both at 30- and 90-days post-stroke (Fig. 2 ). We note, however, that only in this case the cut-off points are different for these two periods.

ROC analysis of PP DMM and 30- and 90-days unfavorable outcome. AUC area under the curve, CI confidence interval, DMM difference maximum-minimum, PP pulse pressure, ROC receiver operating characteristic.
Our study demonstrates that increased PPV in the acute ischemic stroke phase was associated with both short- and long-term unfavorable outcome. Every 10 mmHg increase in the 72-h PPV indices leads to a higher likelihood of unfavorable outcome at 30- and 90-days post-stroke. The association of PPV with functional outcome held up even after adjustment for mean PP values, thrombolysis treatment and other baseline characteristics. We found that all PPV indices were valuable outcome predictors. Our study shows that DMM and MSC indices, which are very easy to compute, are as reliable as other, more complex indicators (CV, SV, SD, ARV). Therefore, DMM and MSC seem the most convenient in clinical practice.
Previous studies evaluated BPV most frequently with the use of SBP and MAP components and demonstrated the association of BPV with poor outcome 90 days after AIS 11 , 12 , 29 , 30 , 31 , 32 . This association was more evident in studies involving patients after reperfusion therapies 12 , 31 , 32 . Some studies found that BPV is associated with the post-stroke outcome only in those patients, who underwent thrombolysis treatment and who did not achieve vessel recanalization, based on imaging examination 30 , 33 . This led to the view that in patients with successful recanalization increased BPV is less of a concern. However, as opposed to MT, in IVT therapy the exact time of recanalization is unknown. Observational studies examining the impact of BPV in patients treated with MT demonstrated a general significant relationship with poor outcome or death, which was not limited to non-recanalized patients 12 , 31 .
The role of PPV in clinical practice is currently underestimated. Up to date only few studies examined the relationship between PPV and stroke outcome 20 , 21 , 22 , 25 . Our results are consistent with other recent reports. Katsanos et al. conducted a study on a group of thrombolysis-eligible patients and found that increased PPV was independently associated with both short- (24-h) and long-term (90 days) outcome 20 . Every 5 mmHg-increase in the 24-h PP SD was independently associated with a 36% decrease in the likelihood of 90-day independent functional outcome. We found the association between PPV and poor outcome in the whole cohort of patients, i.e. with and without thrombolysis treatment. 10 mmHg increase in PP SD was significantly associated with unfavorable outcome at 90 days (OR adjusted = 3.666, 95% CI 1.648–8.156, p = 0.001). Notably, higher Spearman correlation ρ’s were obtained here in the group with thrombolytic treatment (ρ = 0.455 for PP MSC after 90 days outcome). Because of insufficient amount of patients with thrombolysis, we could not include this group in the logistic regression analysis. Another study concerning PPV was carried out on patients with large vessel occlusion stroke treated with MT 25 . In that investigation, PPV 24 h after IAT was associated with poor 3-month outcome and PPV indices had an excellent ability to predict unfavorable outcome (AUC 0.924 for SD). For comparison, in our study, the corresponding results for the whole cohort were lower (AUC 0.664 for SD), but high enough to provide predictive significance (p = 0.000). In both studies, DMM emerged as an equally reliable outcome predictor as more complex indices (CV, SV, SD).
It is worth emphasizing that the significance of PP as a predictor of cardiovascular risk is well established 16 , 34 , 35 , 36 . The relationship between PP and cerebrovascular incidents was less investigated. Lee et al. found that PP in the acute period of stroke had a nonlinear, J-shaped relation with major vascular events, or stroke recurrence 19 . Notably, the predictive power of PP was stronger than that of other commonly used BP parameters (SBP, MAP). Another study demonstrated a non-linear reverse J-curve association between the admission PP level and 3-month post-stroke functional outcomes 37 . By contrast, we have not found any connection between admission PP values and post-stroke outcome after 30 and 90 days.
While MAP is defined as an average blood pressure in aorta and its major branches during the cardiac cycle and it is nearly constant along the arterial tree, PP is considered as a pulsatile component of BP. MAP and PP are dependent variables, though different PP values may occur for a given MAP 38 . It is observed that PP increases markedly with age 39 . Among the causes affecting PP raise, in young individuals stroke volume and ventricular ejection is dominant, whereas in elderly, PP is mainly affected by a reduction in visco-elastic properties of arterial wall and the timing of wave reflection 38 , 40 . Hence, PP is commonly taken as a marker of arterial stiffness. Arterial stiffness was reported to be associated with resistance in cerebral circulation in elderly 41 . It is also suspected to lead to the impairment of the collateral circulation and therefore, to decrease the benefit of recanalization therapies in acute ischemic stroke. Thus future trials investigating the association between PPV and collateral circulation in acute stroke patients are highly needed. Systolic BPV was found to be associated with 90-days post-stroke outcome in patients with poor collateral status, but the data concerning PPV are lacking 42 , 43 .
In our study group, risk factors of achieving worse clinical outcome or death were (1) female sex and (2) previous myocardial infarction. We used those factors as confounders in our logistic regression analysis. The association between BPV and cardiovascular events is well documented. Increased long-term BPV is significantly associated with coronary heart disease incidents and cardiovascular mortality, independent of mean BP 44 , 45 . Greater short-term BPV after acute coronary syndromes is a predictor of major adverse cardiac events 46 , 47 . The impact of sex on the magnitude of BPV and further, on ischemic stroke outcome has not been studied to the best of our knowledge. Women tend to have higher SBP at the time of presentation with AIS and are more likely to have premorbid hypertension 48 . The underlying mechanism for the observed sex differences is not clear, however it has been proposed that female steroid hormones and autonomic dysregulation after menopause are likely to play a role 49 , 50 . There is a great discrepancy in stroke outcome, with women having more severe strokes, less favorable prognoses and greater incidence of death 51 , 52 . Therefore we cannot exclude the possibility that our data may have been influenced by sex differences. In future trials it would be interesting to systematically study the sex disparities in BPV and their association with stroke outcome.
Our study had several limitations. It was a retrospective analysis of a prospective single-center stroke database, which might lead to selection bias and limits the generalizability of the results. The sample size is relatively small in relation to prevalence of the stroke incidents and we have used BP measurements in 4-h intervals, which is larger than suggested in recent literature 13 . The database does not contain the results of imaging techniques (CT, MRI) so that we could not consider secondary outcomes such as symptomatic intracerebral hemorrhage or cerebral infarct volume. In addition, it does not provide information about implemented drug treatments, which is a factor possibly affecting BP values. Importantly, we used standard therapy according to the guidelines, so we don’t expect significant differences in the influence of antihypertension therapy on outcomes in similar cases. As to the adjusted regression analysis, a limited number of clinical cofounders was taken into account, which is also a limitation of our study. The outcome of the study may be also affected by a bias arising from subjective assessments of the caregivers.
Notwithstanding the foregoing, our study confirms the significance of Pulse Pressure Variability in predicting the functional outcome in AIS, both short and long-term. It brings novel insights concerning the usefulness of six different PPV indices (CV, SV, SD, ARV, DMM and MSC), while most studies focus only on two. The provided analysis is comprehensive and combines a wider range of statistical methods than previous studies. The issues addressed here aids the recent search of the best BPV measures applicable in clinical practice and more importantly, provide the predictors of the functional outcome after ischemic stroke treatment.
In conclusion, elevated PPV during the first 72 h after admission as a result of AIS occurrence is associated with unfavorable outcome at 30 and 90 days, and this association is independent of mean BP levels. All considered PPV measures are reliable stroke outcome predictors. Our recommendation is that clinical trials investigating the benefit of reducing BPV by using antihypertensive medication should monitor also PPV values.
Data availability
Data and materials are available on request to the corresponding author.
Qureshi, A. I. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 118 , 176–187 (2008).
Article PubMed Google Scholar
Kamieniarz-Mędrygał, M. & Kaźmierski, R. Ambiguities in blood pressure management in acute ischaemic stroke. Neurol. Neurochir. Pol. 56 , 131–140 (2022).
Powers, W. J. et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49 , e46–e110 (2018).
Berge, E. et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur. Stroke J. 6 , 1–2 (2021).
Article Google Scholar
Levy, D. E. et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 25 , 291–297 (1994).
Article CAS PubMed Google Scholar
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med . 1995;333:1581–1587.
Anderson, C. S. et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet 393 , 877–888 (2019).
RIGHT-2 Investigators. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet . 2019;393:1009–1020.
Vemmos, K. N. et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J. Intern. Med. 255 , 257–265 (2004).
Leonardi-Bee, J., Bath, P. M. W., Phillips, S. J. & Sandercock, P. A. G. IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33 , 1315–1320 (2002).
Minhas, J. S. et al. Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke: a post hoc analysis of the HeadPoST study. J. Hum. Hypertens. 33 , 411–418 (2019).
Article PubMed PubMed Central Google Scholar
Mistry, E. A. et al. Blood pressure variability and neurologic outcome after endovascular thrombectomy: a secondary analysis of the BEST study. Stroke 51 , 511–518 (2020).
Veloudi, P. & Sharman, J. E. Methodological factors affecting quantification of blood pressure variability: a scoping review. J. Hypertens. 36 (4), 711–719 (2018).
Hernandez, M. F. & Chang, T. I. The need to reduce variability in the study of blood pressure variability. Am. J. Kidney Dis. S0272–6386 (22), 01046. https://doi.org/10.1053/j.ajkd.2022.10.008 (2023).
Manning, L. S., Rothwell, P. M., Potter, J. F. & Robinson, T. G. Prognostic significance of short-term blood pressure variability in acute stroke: systematic review. Stroke 46 , 2482–2490 (2015).
Franklin, S. S., Khan, S. A., Wong, N. D., Larson, M. G. & Levy, D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 100 , 354–360 (1999).
Vemmos, K. N. et al. Pulse pressure in acute stroke is an independent predictor of long-term mortality. Cerebrovasc Dis. 18 , 30–36 (2004).
Tsivgoulis, G. et al. Twenty four hour pulse pressure predicts long term recurrence in acute stroke patients. J0 Neurol. Neurosurg. Psychiatry. 76 , 1360–1365 (2005).
Article CAS Google Scholar
Lee, K.-J. et al. Predictive value of pulse pressure in acute ischemic stroke for future major vascular events. Stroke 49 , 46–53 (2018).
Katsanos, A. H. et al. Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis. Eur. J. Neurol. 27 , 2453–2462 (2020).
Maïer, B. et al. Prognostic significance of pulse pressure variability during mechanical thrombectomy in acute ischemic stroke patients. J. Am. Heart Assoc. 7 , e009378 (2018).
Kamieniarz-Mędrygał, M., Łukomski, T. & Kaźmierski, R. Short-term outcome after ischemic stroke and 24-h blood pressure variability: association and predictors. Hypertens Res. 44 , 188–196 (2021).
Teasdale, G. & Jennett, B. Assessment of coma and impaired consciousness. A practical scale. Lancet 2 (7872), 81–84 (1974).
Członkowska, A. & Kobayashi, A. Expert group of the section of cerebrovascular diseases of the polish neurological society [management of acute stroke - guidelines from the expert group of the section of cerebrovascular diseases of the polish neurological society. update 2013: thrombolysis]. Neurol. Neurochir. Pol. 47 , 303–309 (2013).
Yang, M., Lu, T., Weng, B., He, Y. & Yang, H. Association between blood pressure variability and short-term outcome after intra-arterial thrombectomy in acute stroke patients with large-vessel occlusion. Front. Neurol. 11 , 604437 (2020).
Michalak, S. et al. Serum paraoxonase/arylesterase activity affects outcome in ischemic stroke patients. Cerebrovasc. Dis. 32 , 124–132 (2011).
Adams, H. P. et al. Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc. Dis. 18 , 124–129 (2004).
de Havenon, A. et al. Increased blood pressure variability is associated with worse neurologic outcome in acute anterior circulation ischemic stroke. Stroke Res. Treat. 2016 , 7670161 (2016).
PubMed PubMed Central Google Scholar
Endo, K. et al. Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry. Stroke 44 , 816–818 (2013).
Delgado-Mederos, R. et al. Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology 71 , 552–558 (2008).
Bennett, A. E. et al. Increased blood pressure variability after endovascular thrombectomy for acute stroke is associated with worse clinical outcome. J. Neurointerv. Surg. 10 , 823–827 (2018).
Berge, E. et al. Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third international stroke trial of thrombolytic treatment for acute ischemic stroke. Stroke 46 , 3362–3369 (2015).
Martins, A. I. et al. Blood pressure variability in acute ischemic stroke: the role of early recanalization. Eur. Neurol. 80 , 63–67 (2018).
Agabiti-Rosei, E. et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50 , 154–160 (2007).
Millar, J. A., Lever, A. F. & Burke, V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J. Hypertens. 17 , 1065–1072 (1999).
Benetos, A., Rudnichi, A., Safar, M. & Guize, L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 32 , 560–564 (1998).
Tang, S. et al. Low pulse pressure after acute ischemic stroke is associated with unfavorable outcomes: the Taiwan Stroke Registry. J. Am. Heart Assoc. 6 , e005113 (2017).
Safar, M. E. Pulse pressure in essential hypertension: clinical and therapeutical implications. J. Hypertens. 7 , 769–776 (1989).
Safar, M. E. Arterial stiffness as a risk factor for clinical hypertension. Nat. Rev. Cardiol. 15 , 97–105 (2018).
Dart, A. M. & Kingwell, B. A. Pulse pressure—a review of mechanisms and clinical relevance. J. Am. Coll. Cardiol. 37 , 975–984 (2001).
Robertson, A. D., Tessmer, C. F. & Hughson, R. L. Association between arterial stiffness and cerebrovascular resistance in the elderly. J. Hum. Hypertens. 24 , 190–196 (2010).
Liu, D. et al. Adverse outcomes associated with higher mean blood pressure and greater blood pressure variability immediately after successful embolectomy in those with acute ischemic stroke, and the influence of pretreatment collateral circulation status. J. Am. Heart Assoc. 10 , e019350 (2021).
Chang, J. Y., Jeon, S.-B., Jung, C., Gwak, D. S. & Han, M.-K. Postreperfusion blood pressure variability after endovascular thrombectomy affects outcomes in acute ischemic stroke patients with poor collateral circulation. Front Neurol. 10 , 346 (2019).
Wang, J. et al. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J. Hypertens. 35 (1), 10–17 (2017).
Stevens, S. L. et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ 354 , i4098 (2016).
Hassan, A. K. M., Abd-El Rahman, H., Mohsen, K. & Dimitry, S. R. Impact of in-hospital blood pressure variability on cardiovascular outcomes in patients with acute coronary syndrome. J. Clin. Hypertens (Greenwich). 19 (12), 1252–1259 (2017).
Article CAS PubMed PubMed Central Google Scholar
Suzuki, M. et al. Impact of in-hospital blood pressure variability on clinical outcomes in patients with symptomatic peripheral arterial disease. Hypertens Res. 44 (8), 1002–1008 (2021).
Li, J. et al. Sex differences in blood pressure after stroke: a systematic review and meta-analysis. J. Hypertens. 37 (10), 1991–1999 (2019).
Maranon, R. & Reckelhoff, J. F. Sex and gender differences in control of blood pressure. Clin. Sci. (Lond). 125 (7), 311–318. https://doi.org/10.1042/CS20130140 (2013).
Zanchetti, A. et al. SIMONA participants Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J. Hypertens. 23 (12), 2269–2276. https://doi.org/10.1097/01.hjh.0000194118.35098.43 (2005).
Feigin, V. L., Norrving, B. & Mensah, G. A. Global burden of stroke. Circ. Res. 120 (3), 439–448 (2017).
Roquer, J., Campello, A. R. & Gomis, M. Sex differences in first-ever acute stroke. Stroke 34 (7), 1581–1585 (2003).
Download references
Author information
Authors and affiliations.
Department of Neurology, S. T. Dąbrowski Hospital in Puszczykowo, Kraszewskiego Str. 11, 62-041, Puszczykowo, Poland
Maria Kamieniarz-Mędrygał
Poznan University of Medical Sciences, Poznan, Poland
Department of Neurology, Collegium Medicum, University of Zielona Gora, Zielona Gora, Poland
Radosław Kaźmierski
Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland
You can also search for this author in PubMed Google Scholar
Contributions
R.K. conceived the study. M.K.M. was involved in data analysis and wrote the first draft of the manuscript. R.K. reviewed and edited the manuscript. Both authors approved the final version of the manuscript.
Corresponding author
Correspondence to Maria Kamieniarz-Mędrygał .
Ethics declarations
Competing interests.
The authors declare no competing interests.
Additional information
Publisher's note.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ .
Reprints and Permissions
About this article
Cite this article.
Kamieniarz-Mędrygał, M., Kaźmierski, R. Significance of pulse pressure variability in predicting functional outcome in acute ischemic stroke: a retrospective, single-center, observational cohort study. Sci Rep 13 , 3618 (2023). https://doi.org/10.1038/s41598-023-30648-2
Download citation
Received : 12 August 2022
Accepted : 27 February 2023
Published : 03 March 2023
DOI : https://doi.org/10.1038/s41598-023-30648-2
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
By submitting a comment you agree to abide by our Terms and Community Guidelines . If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
Quick links
- Explore articles by subject
- Guide to authors
- Editorial policies
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Login to your account
If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Please enter a term before submitting your search.
- Submit Article
Access provided by

- PDF [1 MB] PDF [1 MB]
- Figure Viewer
- Download Figures (PPT)
- Add To Online Library Powered By Mendeley
- Add To My Reading List
- Export Citation
- Create Citation Alert
Structural brain changes in patients with post-COVID fatigue: a prospective observational study
- Josephine Heine Josephine Heine Affiliations Department of Neurology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Search for articles by this author
- Katia Schwichtenberg Katia Schwichtenberg Affiliations Department of Neurology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Search for articles by this author
- Tim J. Hartung Tim J. Hartung Affiliations Department of Neurology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Search for articles by this author
- Fabian Boesl Fabian Boesl Affiliations Department of Neurology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Search for articles by this author
- Rebekka Rust Rebekka Rust Affiliations Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health and Max Delbrück Center for Molecular Medicine, Berlin, Germany Search for articles by this author
- Carmen Scheibenbogen Carmen Scheibenbogen Affiliations Institute for Medical Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany Search for articles by this author
- Judith Bellmann-Strobl Judith Bellmann-Strobl Affiliations Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health and Max Delbrück Center for Molecular Medicine, Berlin, Germany Search for articles by this author
- Christiana Franke Christiana Franke Affiliations Department of Neurology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Search for articles by this author
- Show footnotes Hide footnotes Author Footnotes i Equal contribution.

Interpretation
- Post-COVID syndrome
- Neuroimaging
- Basal ganglia
Evidence before this study
Added value of this study, implications of all the available evidence, introduction.
- Paterson R.W.
- Benjamin L.
- Scopus (618)
- Google Scholar
- Alfaro-Almagro F.
- Scopus (290)
- Geddes J.R.
- Harrison P.J.
- Full Text PDF
- Scopus (722)
- Penner I.-K.
- Scopus (187)
- Chaudhuri A.
- Scopus (861)
- Dittner A.J.
- Wessely S.C.
- Scopus (580)
- Fietsam A.C.
- Deters J.R.
- Bryant A.D.
- Scopus (76)
- Meyer-Arndt L.
- Scopus (15)
- Scopus (104)
- Scopus (160)
- Hartung T.J.
- Bungenberg J.
- Hohenfeld C.
- Scopus (21)
- Hellgren L.
- Birberg Thornberg U.
- Samuelsson K.
- Divanoglou A.
- Scopus (18)
- Scopus (112)
- Losada P.M.
- Scopus (211)
- Scopus (230)
- Matschke J.
- Lütgehetmann M.
- Scopus (591)
- Scopus (51)
- Fleischer V.
- Gonzalez-Escamilla G.
- Sepulcre J.
- Scopus (155)
- Scopus (69)
Study design and participants
Post-covid patients.
- Open table in a new tab
Healthy controls
Ms patients.
- Bassetti C.L.
- Baumann C.R.
Imaging data acquisition
Imaging data analysis.
- Patenaude B.
- Kennedy D.N.
- Jenkinson M.
- Scopus (1596)
Assessment of fatigue, sleep, neuropsychiatric symptoms, and cognitive function
Choice of primary measure.
- Stöcklin M.
- Calabrese P.
- Scopus (308)
Statistical analysis

- View Large Image
- Download Hi-res image
- Download (PPT)

Role of the funding source
Clinical characteristics, neuropsychiatric and cognitive characteristics, thalamic structural changes, basal ganglia structural changes, white matter integrity, factors associated with post-covid fatigue, comparative analysis in patients with multiple sclerosis and fatigue.
- Haupert S.R.
- Zimmermann L.
- Fritsche L.G.
- Mukherjee B.
- Scopus (102)
- Frontera J.A.
- Scopus (82)
- Calabrese M.
- Scopus (168)
- Demetrashvili M.F.
- Scopus (185)
- Dobryakova E.
- Genova H.M.
- Scopus (110)
- Mehandru S.
- Scopus (124)
- Collorone S.
- di Lazzaro V.
- Scopus (27)
- Grassiot B.
- Scopus (132)
- Audebert H.
- Scopus (19)
- Flanagan K.L.
- Scopus (2344)
Contributors
Data sharing statement, declaration of interests, acknowledgments, appendix a. supplementary data.
- Download .pdf (.32 MB) Help with pdf files Tables S1, S2 and Figure S1
- Download .pdf (.16 MB) Help with pdf files STROBE Statement
- World Health Organization
Article info
Publication history, identification.
DOI: https://doi.org/10.1016/j.eclinm.2023.101874
User license

- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
ScienceDirect
- Download .PPT


Tips for Online Students , Tips for Students
Observational Study: Definitions And Variations

There are many different types of studies out there, each one serving its own unique purpose. Sometimes, it’s difficult to research specific events or phenomena without manipulating an element of the study to produce the results.
An observational study is a type of study that is used for many different purposes today. If you’re curious to learn more about it, keep reading. Here, we’ll cover everything from the observational study definition to how it works, different types, the ethics behind it, and more.
Observational Study Definition
According to a dictionary of medical-related terms by Cancer.gov , the definition of observational study is as follows:
“A type of study in which individuals are observed or certain outcomes are measured. No attempt is made to affect the outcome (for example, no treatment is given).”
In other words, unlike other studies where doctors or scientists attempt to conduct research on things like the effect of new drugs or treatments on a person or illness, in an observational study, no outside factors are added into the mix. In that way, observational studies are not like experiments where external elements usually play a big role.
In an observational study, researchers will attempt to look at a treatment, risk factor, test, or some other type of intervention without changing who is exposed to it. Researchers will make no attempts to manipulate the study in any way, and, as the name implies, their goal with this kind of study is just to observe.
Types of Observational Studies
There are a few different types of observational studies: cohort studies, case-control studies, and experimental studies. Let’s take a closer look at each one.
Cohort studies
In a cohort study, researchers look at people who are linked in a specific way. For example, a birth cohort is a group of people that are born around the same time. Researchers will observe a group to see what happens when each individual is exposed to a certain variable compared to others who aren’t exposed.
Case-control studies
In a case-control study, researchers look for participants with existing health problems, or cases, and then contrast them with other people who don’t have that same problem. They then compare the two groups in relation to different exposures.
Experimental studies
In experimental studies, researchers will introduce some form of intervention and then observe the effects. For example, in a randomized control trial, people are randomly divided into two groups where one group will receive an intervention, like a new drug, and the second will receive nothing or a placebo. Then, researchers will look at what happens to people in both groups and note any differences.
The Strengths and Weaknesses of Observational Studies

Like anything else, observational studies have both strengths and weaknesses. At times, these types of studies are the best way for researchers to look at a certain topic, especially when ethics are involved.
For example, you wouldn’t necessarily expose participants to something harmful or potentially fatal for the purpose of research.
One of the strengths of observational studies is that it is the most efficient way to research certain things, like rare conditions, when applying case-control studies. At other times, cohort studies can be really effective if you’re able to conduct the research over a longer period of time.
That being said, observational studies aren’t without their weaknesses, more specifically, they’re open to bias. As an example, in a cohort study, you might look at the link between elevated blood pressure and people who exercise frequently. However, the bias might be that the people who exercise frequently are already leading a healthier lifestyle and might have better diets than the second group.
Observational Studies and Ethics
As we briefly touched upon earlier, it wouldn’t be ethical to run any type of trial on unsuspecting participants. There are some things that would be considered medically unethical to do in an observational study.
As an example, it would be difficult to conduct a trial of the long-term effects of smoking on the lungs and overall health. In such a study, participants would have to be randomized and put into two groups: those who smoke and those who don’t. These groups would then be observed over time. However, since the long-term effects include things like lung cancer or death, the ethics here are questionable.
This experiment would work if researchers simply surveyed and observed the smoking status of people who are already smokers, but then the test wouldn’t be randomized and other factors and biases can be at play.
Examples of Observational Studies
In order to have a better understanding of observational studies, let’s take a look at some examples.
A simple example of an observational study is someone surveying people on a busy street about any topic, such as their favorite food. Then, this person would take that information and see if there are enough restaurants serving the most commonly answered foods in that area. In this situation, the researcher is simply observing the answers but not influencing the results.
In a second example of an observational study, a researcher might be studying the effects of eating sugary food on a person’s health. In a test group of 400 people, 200 of them will eat sugary foods over a year while another 200 won’t, and then each group will be observed. At the end of the test, each group will be assessed for overall health, and the data will be analyzed in order to come to some conclusion. Again, the researcher here hasn’t manipulated the study itself, just observed the participants.
Hopefully, after reading the observational study definition, examples, and other details, you have a better idea of how it’s used in science and research.
If you’re interested in conducting observational studies and research in your career, then you should start out with a degree in health science . At University of the People, we offer an entirely tuition-free and online health science degree so that you can study the basics before learning more about specific research methods.
Related Articles
Privacy overview.
- Skip to main content
- Keyboard shortcuts for audio player

- subscribe to Planet Money podcast
- Apple Podcasts
- Google Podcasts
- Amazon Music
Planet Money
Exploring seinfeld through the lens of economics.

Sam Yellowhorse Kesler

Kenny Malone
Keith Romer
Alyssa Jeong Perry

The 90s sit-com Seinfeld is often called "a show about nothing." Lauded for its observational humor, this quick-witted show focussed on four hapless New Yorkers navigating work, relationships...yada yada yada.
Jerry, George, Elaine & Kramer set themselves apart from the characters who populated shows like Friends or Cheers , by being the exact opposite of the characters audiences would normally root for. These four New Yorkers were overly analytical, calculating, and above all, selfish.

The economics lessons in kids' books
In other words, they had all the makings of a fascinating case study in economics.
Economics professors Linda Ghent and Alan Grant went so far as to write an entire book on the subject, Seinfeld & Economics . The book points readers to economic principles that appear throughout the show, ideas like economic utility, game theory, and the best way to allocate resources in the face of scarcity.
On today's show, we make the case that Seinfeld is, at its heart, not a show about nothing, but a show about economics. And that understanding Seinfeld can change the way you understand economics itself.
This episode was produced by Alyssa Jeong Perry with help from Emma Peaslee. It was edited by Keith Romer. It was mastered by Robert Rodriguez and fact-checked by Sierra Juarez. Jess Jiang is our acting executive producer.

Here & Now Compass
Something from nothing: 20 years on, the enduring yada yada of 'seinfeld'.
Help support Planet Money and get bonus episodes by subscribing to Planet Money+ in Apple Podcasts or at plus.npr.org/planetmoney .
Always free at these links: Apple Podcasts , Spotify , Google Podcasts , NPR One or anywhere you get podcasts.
Find more Planet Money: Twitter / Facebook / Instagram / TikTok / Our weekly Newsletter .
Music: " Don't Fret ," " Name Your Price ," and " So What Else ."
Press Release
Electrocardiograph (ecg) market expert business study report 2023-2028.
- Facebook icon
- Twitter icon
- Linkedin icon
- Flipboard icon
- Resize icon
The MarketWatch News Department was not involved in the creation of this content.
Mar 06, 2023 (The Expresswire) -- [95 Pages] Top “ Electrocardiograph (ECG) Market ” Size 2023 Key players Profiled in the Report are [, GE Healthcare , Philips Healthcare , Nihon Kohden , Schiller , Opto Circuits , Johnson and Johnson , Mindray Medical , Medtronic ,] most important, influential, or successful companies, brands, or individuals within a Electrocardiograph (ECG) market 2023 to 2028.
Short Description About Electrocardiograph (ECG) Market:
Complete Overview of the Global Electrocardiograph (ECG) Market: - Providing a complete overview of the global Electrocardiograph (ECG) market is a complex task, as there are many different markets and industries around the world. However, I can provide a high-level summary of some of the key trends and factors that are currently impacting the global Electrocardiograph (ECG) market. Economic Growth, Technology, E-commerce, Globalization, Sustainability, Demographics, Political and regulatory risks These are just a few of the many factors that are currently shaping the global market. It is a dynamic and ever-changing environment, and businesses that are able to adapt to new trends and challenges are likely to be the most successful.
Electrocardiograph (ECG) Market Provides High-class Data: - It is true that the global Electrocardiograph (ECG) market provides a wealth of high-quality data for businesses and investors to analyse and make informed decisions. There are many different sources of market data, including government statistics, industry reports, financial news, and market research firms. Some of the key types of data that are available from the global Electrocardiograph (ECG) market include, Economic data, Financial data, Industry data, Consumer data However, it is important to carefully evaluate the quality and reliability of data sources and to use multiple sources of data to gain a more complete understanding of the Electrocardiograph (ECG) market.
Get a Sample Copy of the Electrocardiograph (ECG) Report 2023
Top Country Data and Analysis: - for United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Electrocardiograph (ECG) Markets such as North America, Europe, Asia-Pacific, South America and Middle East and Africa
Description and Analysis of Electrocardiograph (ECG) market : - Electrocardiograph (ECG) Market analysis is the process of evaluating market conditions and trends in order to make informed business decisions. A market can refer to a specific geographic location, particular industry or sector, develop strategies for entering or expanding in a particular Electrocardiograph (ECG) market.
Electrocardiograph (ECG) Market analysis can also involve forecasting future market trends and conditions, based on factors like technological change, regulatory developments, or demographic shifts. This can be used to develop long-term strategic plans and to identify potential risks and opportunities for growth.
Overall, market analysis is an important tool for businesses looking to enter or expand in a particular Electrocardiograph (ECG) market. By carefully evaluating Electrocardiograph (ECG) market conditions and trends, businesses can make more informed decisions and develop strategies that are better aligned with customer needs and Electrocardiograph (ECG) market opportunities.
Get a Sample Copy of the Report at - https://www.industryresearch.biz/enquiry/request-sample/20309212
Market Analysis and Insights: Global Electrocardiograph (ECG) Market Due to the COVID-19 pandemic, the global Electrocardiograph (ECG) market size is estimated to be worth USD million in 2022 and is forecast to a readjusted size of USD million by 2028 with a CAGR of Percent during the review period. Fully considering the economic change by this health crisis, Monitoring ECG Systems accounting for Percent of the Electrocardiograph (ECG) global market in 2021, is projected to value USD million by 2028, growing at a revised Percent CAGR in the post-COVID-19 period. While Home-Based Users segment is altered to an Percent CAGR throughout this forecast period. China Electrocardiograph (ECG) market size is valued at USD million in 2021, while the US and Europe Electrocardiograph (ECG) are USD million and USD million, severally. The proportion of the US is Percent in 2021, while China and Europe are Percent and Percent respectively, and it is predicted that China proportion will reach Percent in 2028, trailing a CAGR of Percent through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR Percent, Percent, and Percent respectively for the next 6-year period. As for the Europe Electrocardiograph (ECG) landscape, Germany is projected to reach USD million by 2028 trailing a CAGR of Percent over the forecast period. The global key manufacturers of Electrocardiograph (ECG) include GE Healthcare, Philips Healthcare, Nihon Kohden, Schiller, Opto Circuits, Johnson and Johnson, Mindray Medical and Medtronic, etc. In 2021, the global top five players have a share approximately Percent in terms of revenue. Global Electrocardiograph (ECG) Scope and Segment Electrocardiograph (ECG) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Electrocardiograph (ECG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Inquire or Share Your Questions If Any Before the Purchasing This Report https://www.industryresearch.biz/enquiry/pre-order-enquiry/20309212
Market segment by Region/Country including: -
User center of Electrocardiograph (ECG) market 2023
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and we elaborate at full length on the impact of the pandemic and the war on the Precious Metals Industry.
Final Report will add the analysis of the impact of COVID-19 on this industry.
TO KNOW HOW COVID-19 PANDEMIC AND RUSSIA UKRAINE WAR WILL IMPACT THIS MARKET - REQUEST A SAMPLE
The Global Electrocardiograph (ECG) market is anticipated to rise at a considerable rate during the forecast period. the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Electrocardiograph (ECG) Market -SegmentationAnalysis:
Report further studies the market development status and future Electrocardiograph (ECG) Market trend across the world. Also, it splits Electrocardiograph (ECG) market Segmentation by Type and by Applications to fully and deeply research and reveal market profile and prospects.
Segment by Type
Which growth factors drives the Electrocardiograph (ECG) market growth?
Increasing use of is expected to drive the growth of the Electrocardiograph (ECG) Market.
Segment by Application
Which market dynamics affect the business?
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
It also provides accurate information and cutting-edge analysis that is necessary to formulate an ideal business plan, and to define the right path for rapid growth for all involved industry players. With this information, stakeholders will be more capable of developing new strategies, which focus on market opportunities that will benefit them, making their business endeavors profitable in the process.
Get a Sample PDF of report @ https://www.industryresearch.biz/enquiry/request-sample/20309212
Electrocardiograph (ECG) Market - Competitive Analysis:
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth. Please find the key player list in Summary.
Electrocardiograph (ECG) Industry leading players are the ones that have the biggest impact, the most market shares 2023, the best reputation, or the highest revenue within their field they are
Who are the Leading Players in Electrocardiograph (ECG) Market?
Both Primary and Secondary data sources are being used while compiling the report. Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters:
1.To study and analyze the global Electrocardiograph (ECG) consumption (value) by key regions/countries, product type and application
2.To understand the structure of Electrocardiograph (ECG) Market by identifying its various sub segments.
3.Focuses on the key global Electrocardiograph (ECG) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Electrocardiograph (ECG) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Electrocardiograph (ECG) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Major Points from Table of Contents
1 Market Overview
1.1 Electrocardiograph (ECG) Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.5 Market Dynamics
2 Manufacturers Profiles
3 Global Electrocardiograph (ECG) Market Competition, by Manufacturer
4 Global Electrocardiograph (ECG) Market Analysis by Regions
5 North America Electrocardiograph (ECG) by Countries
6 Europe Electrocardiograph (ECG) by Countries
7 Asia-Pacific Electrocardiograph (ECG) by Countries
8 Latin America, Middle and Africa Electrocardiograph (ECG) by Countries
9 Electrocardiograph (ECG) Market Segment by Type
10 Electrocardiograph (ECG) Market Segment by Application
11 Electrocardiograph (ECG) Market Forecast (2023-2028)
12 Sales Channel, Distributors, Traders and Dealers
13 Appendix
13.1 Methodology
13.2 Data Source
Key Reasons to Purchase
Purchase this Report (Price 4900 USD for a Single-User License) https://www.industryresearch.biz/purchase/20309212
Market is changing rapidly with the ongoing expansion of the industry. Advancement in technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies a head start in planning and an edge over the competitors. Industry Research is a credible source for gaining the market reports that will provide you with the lead your business needs.
Contact Us: Industry Research Biz Phone : US +1 424 253 0807 UK +44 203 239 8187 Email :[email protected] Web :https://www.industryresearch.biz
Double Edged Blade Market 2023 Top Companies, Industry Outlook | In-depth Analysis Business Opportunities and Demand to 2029
XRF Analyzer Rental Market Size Identification of Industry Development [Potential Resource] Globally and Major Companies to 2029
Positioning Systems Market International BusinessÂAnalysis, Top Winning Strategies, Development Outlook and Regional Strategies 2029
RF Front-end Module Market Five-year Assessment with Latest Technology Analysis [118+ Pages Report]
Online Tennis Gaming Market (New Research Report) By 2023 Which is Experiencing Strong Growth in the Globe till 2029
Private Cloud Server Market Is Booming With Great Opportunities and Growing With Important Updates
Ready-mixed ConcreteÂMarket 2023 Study by Business Opportunities, Top manufacturers Records, Revenue, Price and Gross Margin
Supply Chain Strategy and Operations Consulting Market Report 2023 In-Depth Market Analysis and Future Prospects, Research Report, Growth Trends and Competitive Analysis till 2029
Franchise Merchandise Market 2023, Expert Industrial Investigation, Type, Application 2029
Agriculture Analytics Market Is Booming With Great Opportunities and Growing With Important Updates
Wedding Planning Market Report 2023 In-Depth Market Analysis and Future Prospects, Research Report, Growth Trends and Competitive Analysis till 2029
Oilfield Service Market Size 2023, Competitive Landscape, Regional Status and Prospect Their Application and Type Forecast to 2029
Chlorine Dioxide Market Management of Massive Data and Availability to Hamper the Industry Growth
Islamic Financing Market 2023 (Newest 119 Pages Report) is Booming Worldwide 2029
Insurance Software Market PositionÂAndÂCompany Are Improving And Sharing WorldwideÂWithÂGreat Growth Opportunities
Gradebook Software Market 2023 (Newest 119 Pages Report) is Booming Worldwide 2029
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Electrocardiograph (ECG) Market Expert Business Study Report 2023-2028
COMTEX_425999627/2598/2023-03-06T00:12:32
Is there a problem with this press release? Contact the source provider Comtex at [email protected] . You can also contact MarketWatch Customer Service via our Customer Center .
Partner Center
Most popular.
U.K. stocks at record 40% discount to Wall Street will force London exodus, says Citi
Tesla cuts prices for Model S and Model X in U.S. in bid to boost sales
Paul Manafort settles civil case with Justice Department for $3.15 million
3 ways to prepare your portfolio for a recession
‘We live in purgatory’: My wife has a multimillion-dollar trust fund, but my mother-in-law controls it. We earn $400,000 and spend beyond our means. What’s our next move?
Advertisement, search results, private companies, recently viewed tickers, no recent tickers.
Visit a quote page and your recently viewed tickers will be displayed here.

IMAGES
VIDEO
COMMENTS
An observational study is used to answer a research question based purely on what the researcher observes. There is no interference or manipulation of the research subjects, and no control and treatment groups. These studies are often qualitative in nature and can be used for both exploratory and explanatory research purposes.
In an observational cohort study, subjects are enrolled or grouped on the basis of their exposure, then are followed to document occurrence of disease. Differences in disease rates between the exposed and unexposed groups lead investigators to conclude that exposure is associated with disease.
Case study research is a comprehensive method that incorporates multiple sources of data to provide detailed accounts of complex research phenomena in real-life contexts. However, current models of case study research do not particularly distinguish the unique contribution observation data can make.
Case reports are considered the lowest level of evidence, but they are also the first line of evidence, because they are where new issues and ideas emerge. This is why they form the base of our pyramid. A good case report will be clear about the importance of the observation being reported.
A case report is a detailed description of disease occurrence in a single person. Unusual features of the case may suggest a new hypothesis about the causes or mechanisms of disease. Example: Acquired Immunodeficiency in an Infant; Possible Transmission by Means of Blood Products
potential to reach beyond other methods that rely largely or solely on self-report. This article describes the distinctive characteristics of case study observational research, a modified form of Yin's 2014 model of case study research the authors used in a study exploring interprofessional collaboration in primary care.
We considered it reasonable to initially restrict the recommendations to the three main analytical designs that are used in observational research: cohort, case-control, and cross-sectional studies. We want to provide guidance on how to report observational research well. Our recommendations are not prescriptions for designing or conducting ...
Case-control Study observational epidemiologic study with a comparison group -subjects are grouped according to disease status -diseased -not diseases collect exposure information (historical) on subjects classify subjects according to exposure status -exposed -not exposed organize info into 2 by 2 table Selecting Cases
Case reports and case-series are uncontrolled observational studies. Case Report. A case report only demonstrates that a clinical event of interest is possible. In a case report, there is no control of treatment assignment, endpoint ascertainment, or confounders. There is no control group for the sake of comparison.
ese types of questions. Well-designed observational studies have been shown to provide results similar to those of randomized controlled trials, challenging the belief that observational studies are second rate. Cohort studies and case-control studies are two primary types of observational studies that aid in evaluating associations between diseases and exposures. In this review article, the ...
A field study report focuses on factual and observational details of a project case. It must help the reader understand how theory applies to real-world scenarios. Hence, it should cover the circumstances and contributing factors to derive conclusive results from the observed and collated raw data.
Case reports/studies and case series do not include controls and so, to be considered in a systematic review, these types of studies will need to be well-documented with respect to treatment or other contextual factors that may explain or influence the outcome.
Yes, sometimes the case report involves following the patient over a period of time. No, in a cross-sectional study the exposure and the outcome are measured simultaneously and so there is no need to follow participants over time. Example. In 1991, Fred Kern, Jr. reported the case of an 88-year-old man who has been eating 20-30 eggs each day ...
Observational descriptive study: case report, case series & ecological study Aug. 01, 2021 • 7 likes • 2,764 views Data & Analytics This presentation provides overview on observational study designs Prabesh Ghimire Follow Public Health Professional (MPH) Advertisement Advertisement Recommended 2. Case study and case series Razif Shahril 39.3k views
Like many observational research methods, case studies tend to be more qualitative in nature. Case study methods involve an in-depth, and often a longitudinal examination of an individual. Depending on the focus of the case study, individuals may or may not be observed in their natural setting.
From the Publication Type scroll menu, select either Case Reports, Case Study, or Observational Study . After you have your results, make sure to read through the article abstracts to see which type of study design the researchers are using. There is no guarantee that the database will only generate these types of studies.
We identified published reports of randomized, controlled trials and reports of observational studies with either a cohort design (i.e., with concurrent selection of controls) or a case-control ...
Observational studies in epidemiology (cohort, case-control studies, cross-sectional studies) STROBE checklist: combined ... cohort, case-control, and cross-sectional studies. We want to provide guidance on how to report observational research well. Our recommendations are not prescriptions for designing or conducting studies. ...
Areas covered: : This review compiles safety and tolerability data from all published observational studies, registry analyses, and case reports identified in systematic searches in which nabiximols oromucosal spray was investigated for spasticity (n = 20) and/or chronic non-cancer pain (n = 4).
This study aimed to determine the association between pulse pressure variability (PPV) and short- and long-term outcomes of acute ischemic stroke (AIS) patients. We studied 203 tertiary stroke ...
We found meta-analyses, observational cohort studies, and larger case series (>100 patients) reporting an estimated prevalence of postacute fatigue of ∼30% patients with COVID-19 that is associated with cognitive deficits and decreased quality of life. A large study using data from the UK Biobank reported brain changes related to SARS-CoV-2 ...
In an observational study, researchers will attempt to look at a treatment, risk factor, test, or some other type of intervention without changing who is exposed to it. Researchers will make no attempts to manipulate the study in any way, and, as the name implies, their goal with this kind of study is just to observe. Types of Observational Studies
Published Mar 5, 2023. + Follow. The Norwait study is an example of an observational study where procedural failings have resulted in patients with active cancers being included in an ...
In other words, they had all the makings of a fascinating case study in economics. Economics professors Linda Ghent and Alan Grant went so far as to write an entire book on the subject, Seinfeld ...
1.To study and analyze the global Electrocardiograph (ECG) consumption (value) by key regions/countries, product type and application. 2.To understand the structure of Electrocardiograph (ECG ...